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Abstract
Maintaining the integrity of sperm DNA is vital to reproduction and male fertility. Sperm contain a
number of molecules and pathways for the repair of base excision, base mismatches and DNA
strand breaks. The presence of Poly (ADP-ribose) polymerase (PARP), a DNA repair enzyme, and
its homologues has recently been shown in male germ cells, specifically during stage VII of
spermatogenesis. High PARP expression has been reported in mature spermatozoa and in proven
fertile men. Whenever there are strand breaks in sperm DNA due to oxidative stress, chromatin
remodeling or cell death, PARP is activated. However, the cleavage of PARP by caspase-3
inactivates it and inhibits PARP's DNA-repairing abilities. Therefore, cleaved PARP (cPARP) may be
considered a marker of apoptosis. The presence of higher levels of cPARP in sperm of infertile men
adds a new proof for the correlation between apoptosis and male infertility. This review describes
the possible biological significance of PARP in mammalian cells with the focus on male reproduction.
The review elaborates on the role played by PARP during spermatogenesis, sperm maturation in
ejaculated spermatozoa and the potential role of PARP as new marker of sperm damage. PARP
could provide new strategies to preserve fertility in cancer patients subjected to genotoxic stresses
and may be a key to better male reproductive health.
Background
Male fertility is affected by a variety of environmental,
behavioral, and genetic factors that can alter spermatogen-
esis at various levels [1-3]. Male germ cells are exposed to
a wide variety of endogenous and exogenous genotoxic
agents. Endogenous agents include reactive oxygen and
nitrogen species generated during the metabolic activities
of cells [4,5]. Exogenous agents include various environ-
mental factors that can inflict damage to genomic DNA.
These genotoxic agents can introduce DNA lesions in the
form of DNA single and double strand breaks, abasic sites,
base damage, inter-and intra-strand cross links and DNA-
protein cross links [6,7]. Origin of DNA damage in
human spermatozoa can occur by abortive apoptosis,
abnormal chromatin packaging, generation of reactive
oxygen species and premature release from Sertoli cells [8-
12].
During spermatogenesis, germ cell DNA in the nucleus is
nicked by topoisomerases in order to relieve the torsional
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stress created when DNA is compacted into the differenti-
ating sperm head. Persistence of DNA strand breaks dur-
ing different stages of spermatogenesis contribute to DNA
damage detected in mature spermatozoa [13,14]. As sper-
matids are haploid, they must resolve double stranded
DNA breaks by an error-prone DNA repair mechanism
[15]. Interest in male germ cell DNA quality has increased
in recent decades especially in the era of assisted reproduc-
tive technologies (ART). As natural selection of spermato-
zoa for fertilization is bypassed in procedures such as
intracytoplasmic sperm injection (ICSI), awareness has
been raised regarding the possibility of congenital anom-
alies. Many reviews have dealt with the origin of sperm
DNA integrity, evaluation of available technologies to
assess sperm DNA integrity and its impact on the outcome
of ART [16-24]. Environmental, life style and occupa-
tional hazards in male infertility have also been exten-
sively studied [25-33]. These factors may affect DNA
repair pathways and impact male fertility and subsequent
embryo development.
In this review we will discuss the role of Poly (ADP-
ribose) polymerase (PARP), a DNA damage repair pro-
teins and highlight its role in ejaculated human spermato-
zoa. Recently the focus of PARP's role in malignancy has
intensified to include use of PARP inhibition as an adju-
vant therapy with chemotherapeutic drugs [34]. As our
interest lies primarily in male reproductive health, in this
review we will focus on the biological role of PARP in gen-
eral as well as in male gamete and highlight possible role
of PARP in modulating DNA damage in male germ cells.
Poly (ADP-ribose) polymerase (PARP)
Poly (ADP-ribose) polymerase (PARP), a nuclear enzyme
has a particularly well-researched role in base excision
repair; it is one of the primary repair mechanisms to
resolve DNA lesions caused by endogenous processes as
well as those caused by exogenous chemical exposure and
irradiation [35,36]. PARP also has a well-documented role
in testicular germ cells [37-39], including a role in DNA
damage repair of germ cells [40]. However, a similar role
for PARP in human ejaculated spermatozoa is still being
investigated. The last decade has seen increasing interest
in the relationship between DNA integrity in mature ejac-
ulated spermatozoa and male infertility [16,26,41-43].
Focus on genomic integrity of the male gametes has been
further intensified by the growing concern about the
transmission of genetic diseases through intracytoplasmic
sperm injection (ICSI) [44-49].
Proteins involved in the major repair pathways have been
shown to be expressed in the testis [50]. PARP proteins are
involved in detection of strand breaks and signaling in
both the base excision repair and nucleotide repair path-
ways [51,52]. PARP catalyzes poly (ADP-ribose) (PAR)
polymerization from donor NAD+ molecules into target
proteins. PARP1 is the prototype and most abundantly
expressed member of a family of PARPs.
The PARP family consists of 18 homologues (PARP 1-18)
with a conserved catalytic domain made up of 50 amino
acid residues that serve as the 'PARP signature' [53]. This
is the site where poly(ADP-ribose) (PAR) chains are initi-
ated, elongated, and where branching of the chains can
occur [54]. Besides this catalytic domain, PARP family
members may also have other domains including DNA
binding domains, macro-domains, breast cancer-1
(BRCA-1) C-Terminus (C-T) domain, ankyrin repeats and
a domain associated with protein-protein interaction
called WWE. BRCA-1 C-T domains are characteristic of
proteins responding to DNA damage at cell cycle check-
points while WWE domains are found in proteins associ-
ated with ubiquitination. All of these special types of
domains contribute to the unique functions of each fam-
ily member [53,55,56].
PARP family members can be divided into several sub-
categories or groups based on each protein's established
functional domains and precise functions into: 1) DNA
dependent PARPs (PARP1 and PARP2) that are activated
by DNA strand breaks 2) Tankyrases (tankyrase-1 and
tankyrase-2) that serve diverse functions such as telomere
regulation and mitotic segregation 3) CCCH-type PARPs
(PARP12, PARP13) which contain special CCCH type zinc
fingers and 4) PARP9, PARP14, and PARP15 consisting of
macro PARP's which have 1-3 macrodomains connected
to a PARP domain. They also have WWE domain and
PARP catalytic activity. PARP6, 8, 11 and 16 do not have
any recognized domains or functions and therefore they
have not been assigned proper nomenclature [56].
Recent classification system by Hassa and Hottiger groups
PARPs on the basis of their catalytic domain sequences
[54]. PARP family is divided into 3 separate groups: 1)
PARP1, PARPb (short PARP1), PARP2, and PARP3, 2)
PARP4 and 3) 2 PARP members, Tankyrase-1, tankyrase-
2a, and its isoform tankyrase-2b (also known as PARP5
and PARP6a/b) [54]. The various PARP enzymes can also
have different subcellular localization patterns. PARP1
and 2 are considered nuclear enzymes and are found in
the nucleus of cells. In contrast, tankyrases and PARP3 are
found in both the nucleus and cytoplasm [54,57].
Perhaps the best studied member of the PARP family is
PARP1, a 113 kD enzyme encoded by the ADP-ribosyl
transferase (ADPRT) gene in humans located on chromo-
some 1 [58,59]. PARP1 has been reported to be involved
in regulation of chromatin structure and transcription
processes in response to specific signaling pathways [55].
The protein structure of PARP1 is well characterized. Fig-Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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ure 1 represents the PARP1 structure domains with clarifi-
cation on the sites of the zinc fingers, PAR acceptance, and
cleavage site with short and long cleaved PARP1 frag-
ments. PARP1 is made up of 3 functional domains includ-
ing DNA binding domain (DBD), automodification
domain (AMD) and catalytic domains (CD). The DNA
binding domain contains zinc fingers that can bind to
breaks in DNA and contains the nuclear localization sig-
nal (NLS), which ensures the translocation of PARP1 into
the nucleus and also forms a site of cleavage by caspase 3.
The AMD is responsible for addition of ADP-ribose poly-
mers to PARP1 itself. The catalytic domain is responsible
for the PARP activity [60] (Figure 1).
The DNA binding domain extends from the initiator
methionine (M) to threonine (T) 373 in human PARP1,
and contains 2 well known structurally and functionally
unique zinc fingers (FI: amino acid 11-89; FII: amino
acids 115-199) [61,62]. A recently discovered third and
thus far an unrecognized zinc-binding motif, (FIII: amino
acid 233-373) has been reported [63,64]. DNA binding
domain contains a bipartite nuclear localization signal
(NLS) of the lysine (K) rich form KRK-X-KKKSKK (amino
acid 207-226) that targets PARP1 to the nucleus [65]. Zinc
fingers FI and FII are thought to recognize altered struc-
tures in DNA rather than particular sequences. These zinc
fingers have been reported to be involved in protein - pro-
tein interactions [66]. PARP1 strongly associates with sin-
gle and double strand DNA breaks generated either
directly by DNA damage or indirectly by the enzymatic
excision of damaged bases during DNA repair processes.
Structural domians of PARP and its fragments showing Figure 1
Structural domains of PARP and its fragments showing. A: DNA binding domain containing Zinc fingers (F1-F3) for 
nucleosome binding and nuclear localization (NLS) segment; Automodification domain responsible for adding ADPR (ADP 
ribose) polymers through binding with Lysine (K) amino acid and catalytic domain has the PARP signature and PARP enzymatic 
activity. B: Full length PARP1 113 KDa molecule with a mark on the site of cleavage (214/215 amino acids) C: PARP cleavage by 
caspase showing short (24 KDa) and long (89 KDa) cleaved PARP fragments.Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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Several studies suggest that the first zinc finger is required
for PARP1 activation by both DNA single and double
strand breaks, whereas the second zinc finger may exclu-
sively act as a DNA single strand break sensor [61,62,67].
Additional studies are necessary for further identification
of interactions/localization of PARP or different muta-
tion/polymorphisms of PARP in the pathophysiology of
oxidative stress, apoptosis and malignancies [68].
The major PAR acceptor protein is PARP1 itself, which
appears to accumulate roughly 90% of cellular PAR via
PARylation of its auto-modification domain. NAD is the
substrate of PARP enzymes that becomes cleaved forming
ADP-ribose and nicotinamide (Figure 2). Binding of mon-
omer of ADP-ribose with PARP1 is mainly through hydro-
gen bonds on the c-terminus mainly the automodification
domain [53]. Interestingly, Altmeyer et al (2009) showed
that glutamic acid residue in the automodification
domain of PARP1 is not required for PAR formation.
Instead they identified lysine residues to be the PAR accep-
tor sites in PARP1 [67].
Role of PARP in metabolic pathways
The real challenge and the difficulty in understanding
PARP interaction and PAR metabolism is the lack of struc-
tural information that can be provided by X-ray crystallog-
raphy or by nuclear magnetic resonance (NMR). Prior to
the recent findings by Altmeyer et al [67], the intense
PARP interactions in DNA damage/repair showing Figure 2
PARP interactions in DNA damage/repair showing. A: DNA damage caused by genotoxic agents activates PARP with 
HSP70 (heat shock protein 70) providing further activation B: activation of PAR formation with further help from other DNA 
repair proteins such as XCCR1 (X-ray repair complementing defective repair in Chinese hamster ovary cells) that help DNA 
polymerase to start sealing the damaged DNA strand C: DNA polymerase and ligase seal the DNA nicks releasing PARP and 
other DNA binding proteins and D: repaired DNA.Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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research on PARP was unable to confirm the presence of
glutamic acid residue in the AMD that may be functioning
as the PAR acceptor of amino acid in PARP1 [69]. This was
mainly due to the lack of mutational studies for PARP.
Figure 2 explains the possible PARP interaction with the
main proteins involved in DNA repair during DNA dam-
age/repair process. The primary catalytic function of PARP
enzymes is to transfer ADP-ribose groups to the gluta-
mate, aspartate and carboxy-terminal lysine residues of
proteins. With NAD serving as a cofactor, PAR polymeri-
zation begins by breaking the glycosidic bond between
ADP-ribose and nicontinamide. PARP can elongate the
amino acid chains of recipient proteins in a linear or
branched manner by the addition of up to 200 ADP-
ribose groups [70].
PARP attaches ADP-ribose groups to a variety of protein
substrates. Perhaps the most common target of (ADP-
ribosyl)ation is PARP1 itself, termed auto-modification
[71]. PARP enzymes commonly modify nucleosome pro-
teins in order to restructure chromatin. While both his-
tone H1 and H2B are acceptors of poly ADP-ribose,
histone H1 is the major acceptor recipient [72,73]. His-
tone H1t, a major H1 variant in testis, is the main H1 tar-
get of PARP during spermatogenesis [74]. PARP activity is
not restricted to nuclesome proteins; the well-known
tumor suppressor protein p53 is also modified by PARP1.
This modification transcriptionally inactivates p53 [75].
DNA polymerases modified by PARP have also been
inhibited during in vitro studies [76]. Toposiomerase II
can also be modified by PARP activity [77]. Similarly, the
transcription nuclear factor kappa β (NF-kβ) can also be
modified by ADP-ribose group attachment [78].
Regulation of PARP activity is important for exploring the
therapeutic options of this enzyme. Several types of mol-
ecules have been identified as activators of PARP activity
including histones, a common target of PARP. Though
histones H1 and H2B are modified by PARP1, histones
H1 and H3 reciprocally activate PARP1 [79,80]. Apart
from ribosylation, the structure of histones is regulated by
acetylation and silent information regulator gene (SIRT1),
a histone deacetylase, involved in the maintenance of his-
tone structure. SIRT1 has a regulatory action on PARP1
activity and in the absence of SIRT-1, PARP remains
unregulated resulting in apoptosis inducing factor (AIF)
regulated cell death [81]. PARP activity is also activated by
a number of metal ions (like magnesium and calcium)
and polyamines. Incidentally, calcium ions also play an
important role in the pathophysiology associated with
oxidative stress and could provide a link to explain the
effect of oxidative stress on PARP activity [82-86].
There are a number of inhibitors used to study PARP activ-
ity such as endogenous purines (hypoxanthine and inos-
ine) or exogenous molecules like caffeine derivatives or
tetracycline derivatives [80,87]. PARP1 phosphorylation
by ERK1/2 is required for maximal PARP1 activation after
DNA damage [88]. Furthermore DNA-dependent protein
kinase (DNA-PK), a protein involved in the repair of dou-
ble strand breaks results in suppression of PARP activity
probably through direct binding and/or sequestration of
DNA-ends which serve as an important stimulator for
both DNA-PK and PARP [89].
PARP in mammalian cells
The most important role of PARP is its capacity to repair
DNA, especially in resolving single strand breaks. PARP1
and PARP2 have been shown to function in the repair of
base excision [60]. Additionally, PARP1 may play a role in
an alternate version of double strand DNA break repair
involving the DNA repair protein XRCC1 (X-ray repair
complementing defective repair in Chinese hamster ovary
cells 1) along with Ligase III and DNA-dependent protein
kinase involved in resealing DNA breaks [90,91]. PARP
interactions and it's role in the DNA repair process is
explained in Figure 2. PARP1/PARP2 get activated with
DNA breaks and interact along with other main DNA
repair proteins (XRCC1, DNA polymerase, DNA ligase III,
and other DNA binding proteins to repair the damaged
DNA strand. Heat shock protein may provide additional
activation for the PAR formation early in the DNA repair
[92] (Figure 2).
PARP1 binds to broken strands of DNA and automodifies
itself. It then dissociates from the single DNA strand due
to the negative charge it acquires from the ADP-ribose
group. After dissociating, PARP associates with DNA
Ligase III alpha, which is involved in the resealing of DNA
breaks, and XRCC1. XRCC1 then recruits other repair fac-
tors (such as DNA polymerase β, apurinic-apyrimidinic
(AP) endonuclease, and polynucleotide kinase) to com-
plete the repair process [93]. Thus, PARP1 is part of an
important signaling pathway for DNA damage repair due
to its ability to recruit other repair enzymes necessary to
preserve DNA integrity of a cell. The role of PARP1 in base
excision repair (BER) was recognized by its interaction
with DNA polymerase β and its interaction with DNA
Ligase III and XRCC1. It was also shown that PARP1 defi-
cient cells demonstrated significantly inhibited BER activ-
ity [94].
Similarly, PARP2 has also been shown to participate in
BER pathways, associating with DNA polymerase β,
XRCC1, and DNA Ligase III [51]. PARP2 deficient mice
showed significant delays in resealing single strand DNA
breaks similar to those seen in PARP1 deficient mice. This
is interesting because PARP2 activity is 10 times less than
that of PARP1. PARP1 and PARP2 also appear to
homodimerize and heterodimerize as a part of DNAReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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repair [51]. PARP not only serves as part of a signaling
pathway in DNA damage repair but it is also involved in
the repair process. In particular, the binding of PARP1 to
the broken ends of DNA may protect it from degradation
by nucleases [95]. NBS1 (Nijmegen Breakage Syndrome
1) has been recently reported to be required for base exci-
sion repair (BER) [96].
A model put forth recently suggests that the involvement
of PARP in DNA damage repair is regulated by a feedback
mechanism [97]. PARP1 is first recruited to the DNA
break site and then binds to this site through its DNA
binding domain. The addition of PAR units enables the
recruitment of more PARP1 moieties through the AMD of
PARP1. The aggregation of PARP molecules then creates a
signal that recruits other repair factors and forms the pos-
itive feedback mechanism of PARP. Interestingly, PARP
activity is subject to a negative feedback mechanism that
prevents excessive accumulation of poly (ADP-ribose)
and cell death [98,99].
PARP in cell cycle and cell death
In addition to being involved in the rescuing function of
DNA repair, PARP1 is also directly involved [100] in both
programmed cell death as well as necrosis [101-103] (Fig-
ure 3). PARP is part of the caspase-dependent pathway of
apoptosis and as part of this caspase mediating pathway;
PARP1 is cleaved by Caspase-3 into a 25 kDa N-terminal
and an 85 kDa C-terminal fragment. The 25 kDa fragment
consists of the DBD and the 85 kDa fragment consists of
Possible role of PARP in cell death in the event of DNA damage caused by ROS or a genotoxin, PARP targets the damaged site Figure 3
Possible role of PARP in cell death in the event of DNA damage caused by ROS or a genotoxin, PARP targets 
the damaged site. If high damage occurs, PARP may become overactivated resulting in ATP/NAD depletion and necrosis. 
Apoptosis can also occur through caspase-3 activation and PARP cleavage. If low damage occurs, PARP can recruit other repair 
enzymes and DNA repair can occur. Recently PARP1 dependent cell death termed as parthanatos has been reported, and is 
distinct from apoptosis, necrosis or autophagy. Each arrow represents one or more reaction(s).Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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the AMD and CD (Figure 1). The detachment of the DNA-
binding domain from the automodification and catalytic
domains inactivates PARP1 and allows apoptosis to occur
[104]. Meanwhile, the N-terminal fragment inhibits any
uncleaved PARP1 molecules that are still present. Thus,
PARP1 cleavage effectively inhibits PARP activity that
could result in energy depletion as a result of consump-
tion of a significantly large number of Nicotinamide ade-
nine dinucleotide (NAD) molecules and lack of
ribosylation [105]. PARP1 is also involved in a caspase-
independent cell death pathway. When PARP1 is activated
by exposing fibroblast cultures to hydrogen peroxide-
induced damage, it triggers caspase-independent path-
way. PARP activation triggers the release of AIF from the
mitochondria and causes it to relocate to the nucleus
resulting in chromatinolyis [55,106-108].
PARP is also involved in a less organized version of cell
death-necrosis. Originally Berger et al proposed that
depletion of NAD caused an over-activation of PARP and
in the milieu of excessive DNA damage can cause necrosis
[109]. Heeres and Hergenrother proposed that over-accu-
mulation of poly (ADP-ribose) are cytotoxic to cells and
induce them to undergo necrosis.
Thus PARP appears to be a two-sided coin. It has the
potential to respond to threats to DNA integrity, but its
over-activation can lead to cell death [101]. Figure 3 rep-
resent a schematic pathways that link the reactive oxygen
species (ROS) and genotoxins induced DNA damage with
the ATP/NAD levels that may determine the cell death
pathway depending upon the extent of the DNA damage,
caspase activation, and ATP/NAD levels. Modification of
PARP activity through inhibition or cleavage may lead to
apoptosis by preventing DNA repair provided by PARP.
However, recent report indicate that PARP may lead to
PARP1 dependent cell death that is reported to be distinct
from apoptosis, necrosis or autophagy and it is called
parthanatos [110].
The role of PARP in maintaining genomic integrity could
have profound implications for cell division. PARP is
associated with specific structures important for cell divi-
sion such as centromeres and centrosomes, pointing to its
possible role in cell division. PARP1 associates with cen-
trosomes during cell division and interphase, which may
be related to PARP1's role in maintaining chromosome
stability [111]. PARP1 is also involved in spindle struc-
tures necessary for cell division. Poly (ADP-ribosyl)ation
of spindle structures is essential for normal functioning
and assembly of spindles that if disturbed could result in
defective chromosome segregation [112,113]. PARP3 also
demonstrated an interaction with PARP1 at centrosomes
[57]. PARPs localize to active mammalian centromeres
primarily during metaphase and prometaphase
[114,115]. PARP1 and PARP2 bind to the same centro-
mere proteins, including the important mitotic check-
point protein and Bub3 (budding uninhibited by
benzimidazoles 3) [55].
Chromatin remodeling and transcription
Poly (ADP-ribosyl)ation can be considered an epigenetic
modification [116] because its modification of histones
can remodel chromatin structure in order to provide
unique information for other proteins involved in not
only DNA repair but also in transcription [55,97]. The
role of PARP in transcription is a result of two important
aspects of its function: its modification of histones and
interaction with other coactivators and DNA binding fac-
tors to bind to the enhancer promoter regions [117-119].
The chromatin environment is very important for tran-
scription and the role of PARPs in chromatin remodeling
has been well documented [55,108]. PARP has been
found to associate with the Facilitates of Chromatin Tran-
scription (FACT) complex, a protein complex involved in
chromatin remodeling. Poly (ADP-ribosyl)ation of the
FACT complex prevents the interaction between FACT and
nucleosomes in vitro [120]. As mentioned before, Histone
H1 and H2B are major acceptors of PARP modification
and this modification can also remodel chromatin struc-
ture [116]. Specifically poly (ADP-ribosyl)ation of nucle-
osome structures can cause relaxation of chromatin
structure [116,121,122].
In a recent study, PARP1 was shown to be broadly distrib-
uted across the human genome. Furthermore, PARP1 and
histone H1 were shown to have reciprocal roles in regulat-
ing gene expression. When there is increased presence of
PARP and decreased presence of H1 at promoter regions
of genes, the genes are activated in 90% of the cases. When
gene promoters had both decreased presence of PARP and
H1, less than 45% of genes were expressed [123]. Tulin
and Spalding reported that PARP can activate the tran-
scription of heat shock proteins in Drosophila by
decondensing chromatin structure [108]. This was in con-
tradiction to the study of Oei et al who showed that poly
(ADP-ribosyl)ation of transcription factors for TATA-
binding protein (TBP) or YinYang1 (YY1) prevented these
transcription factors from binding DNA [124]. However,
once TBP or YY1 were bound to DNA, they were immune
to the action of PARP. Therefore, PARP cannot dislodge
TBP or YY1 once they are bound to DNA. In this way,
PARP can prevent transcription in specific parts of the
genome without disturbing ongoing transcription
[60,125,126].
PARP interacts with transcription factors at enhancer and
promoter regions via its involvement with NF-κβ,
[23,78,127,128]. PARP-NF-κβ interactions have impor-Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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tant consequences for inflammation. PARP1 deficient
mice cloned by Oliver et al were resistant to endotoxic
shock normally induced by exposure to lipopolysaccaride
(LPS) [102]. This could be a result of decreased expression
of genes controlled by NF-κβ [35,97,126,129,130].
The epigenetic role of PARP extends to other genomic
structures besides histones. Poly (ADP-ribosyl)ation of
the CCCTC-binding factor (zinc finger protein) CTCF
gene, a chromatin insulator encoding protein has been
shown to affect the ability of this protein to interact with
over 140 target sites in mice [107,131-133]. The role of
PARP in controlling the function of the CTCF insulator in
the regulation of the transcriptional states of various genes
further demonstrates the role of PARP in epigenetics
[134,135].
Poly (ADP-ribose) glycohydrolase (PARG) and PARP 
interactions
Poly (ADP-ribose) glycohydrolase or PARG is an enzyme
involved in poly (ADP-ribose) metabolism. PARG
removes PAR units from proteins and thus plays an
equally important role as PARP in cellular function.
Though PARG is found in the cytoplasm rather than the
nucleus where PARP is found [136], PARG can be trans-
ported between the nucleus and cytoplasm in order to reg-
ulate the breakdown of poly (ADP-ribose) [137]. It was
found that a PARG deficiency in mice was lethal because
of an accumulation of poly (ADP-ribose) [138].
Specifically, PARG maintains chromatin structure by
removal of poly(ADP-ribose) and by acting in opposition
to PARP return chromatin to its original state. PARG
accomplishes this by removing PAR groups from histones
and once again allowing histones to form the nucleosome
structure of chromatin [137]. PARG is involved in DNA
repair by regulating the amount of PAR synthesized in
response to DNA damage since excessive accumulation of
PAR may result in cell death [101]. PARG and PARP work
in opposition to each other to modify chromatin structure
[117,122]. When PARP creates transcriptionally active
regions of chromatin, PARG restores chromatin to its orig-
inal state. However, PARP does not always transcription-
ally activate chromatin regions. For instance, in
euchromatin regions, PARP is involved in chromatin
decondensation and promoting transcription while in
heterochromatin regions it could repress transcription
[117]. Knocking out of PARG was found to be lethal in
mouse embryonic cells at day 3 of gestation since PARG is
the primary enzyme involved in breaking down PAR in
cells [138].
Due to its abilities to regulate the ADP-ribose that is
required for protection against DNA damage, PARG is
involved in cellular responses to oxidative stress [139]. In
a recent study by Fisher et al, PARG was found to cooper-
ate with PARP1 in responding to oxidative damage by reg-
ulating XRCC1 at DNA break sites created by oxidative
damage [140]. PARG has also been shown to protect
against cell damage caused by genotoxic or oxidative
stress even at sub-lethal levels by regulating PAR [138].
Role of PARP in germ cell death
Apoptosis is a normal component of mammalian sperma-
togenesis. It is orchestrated spontaneously during the
entire stages of spermatogenesis in order to produce
mature spermatozoa and to eliminate any abnormal sper-
matozoa. In fact, a very large number of spermatozoa die
and are eliminated during spermatogenesis. This may be
due to the ability of the Sertoli cells to maintain only a
limited number of germ cells and resulting in the elimina-
tion of excess germ cells. Apoptosis may also function to
destroy cells that do not make it past certain cellular
checkpoints [141] Evidence seems to point to the notion
that germ cell death during mitotic and meiotic cell divi-
sions may be needed to eliminate problems such as errors
in chromosomal arrangement during meiosis or unre-
paired breaks in DNA. More importantly, apoptosis may
be needed to prevent genetic abnormalities from being
passed onto offspring [142]. In a recent study, Codelia et
al examined which cell death pathway was involved in
pubertal rat spermatogenesis. Using a caspase-8 inhibitor
and a pan-caspase inhibitor they detected significantly
less cleaved PARP and also a reduction in the number of
apoptotic germ cells suggesting that germ cell apoptosis
occurs via the Fas antigen (Fas)-Fas ligand (Fas-FasL) sys-
tem and that PARP cleavage may play a key role [143].
Not only does PARP have a well-defined role in DNA
repair, but it is also involved in apoptosis. During apopto-
sis, numerous DNA strand breaks can lead to PARP activa-
tion. This activation of PARP may be an attempt by the
dying cell to repair the DNA damage caused by nuclease
activation [129,144,145]. However, this attempt to repair
damage proves futile as PARP is cleaved by caspase-3 into
a catalytic fragment of 89 kDa and DNA binding unit of
24 kDa [61,146]. Therefore, this cleaved version of PARP
could be a biochemical marker of caspase-dependent
apoptosis [147,148].
Deregulation of germ cell death can have important
implications for male fertility. Patients with contralateral
testes exhibit an increased incidence of apoptosis. The
presence of apoptotic markers is high in these patients
especially in spermatocytes, early and late spermatids, and
Sertoli cells [149]. Infertile men with spermatid and sper-
matocyte maturation arrest and hypospermatogenesis
also show increased apoptosis [150]. Specifically, the Fas-
FasL pathway and active caspase 3 showed increased activ-
ity in testes with maturation arrest and Sertoli cell-onlyReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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syndrome (SCOS) [127,151]. Increased rate of apoptosis
seen with these infertility cases may be due to elimination
of germ cells with extensive DNA damage. Tesarik et al
compared men with complete spermiogenesis failure to
another group of azoospermic men who had incomplete
failure of spermiogenesis and were able to show that
apoptotic DNA damage was greater in the latter group
when compared to the former. This increase in DNA dam-
age seen in patients with complete spermiogenesis failure
could be responsible for the low conception success rates
in these cases [152]. In a more recent study, Maymon et al
proposed that the presence of greater PAR levels in human
spermatocytes during maturation arrest could be corre-
lated with the greater occurrence of DNA strand breaks
during impaired spermatogenesis [153].
PARP2 has also been implicated in abnormal sperma-
togenesis. In a recent study by Dantzer et al, PARP2 defi-
cient male mice were found to have hypofertility [154].
Upon examination of infertile PARP2 null mice, an
increased incidence of testicular apoptosis was found spe-
cifically in the spermatocyte and spermatid layers. How-
ever, the layers containing spermatogonia and
preleptotene spermatocytes were normal. Chromosome
segregation was abnormal during metaphase I and spin-
dle assembly was also abnormal in these PARP2 deficient
mice. Thus, the decrease in fertility seen in these PARP2-
null mice could be related to both defective meiosis I and
spermiogenesis [81]. These results make it increasingly
clear that apoptotic markers can be excellent diagnostic
tools for evaluating fertility potential.
Exogenous agents applied to the testes may also activate
caspase-dependent cell death pathway. For example,
when the scrotal temperature was increased in rats over
time, the mitochondria dependent cell death pathway in
the testis was activated. The signaling cascade involved
relocation of Bax, translocation of cytochrome C, activa-
tion of caspases, and the cleavage of PARP [155].
Although the precise role of PARP in exogenously induced
apoptosis is not clear, a study of PARP's protein targets
may help elucidate this role. Following exogenous stress,
increase in levels of p53 are considered to be a part of the
mechanism that returns spermatogenesis to normal cycles
following apoptosis. P53 is a downstream protein poly
(ADP-ribosyl)ated by PARP [71,75,156]. Under condi-
tions of inflammation, PARP poly (ADP-ribosyl)ates and
activates NF-κβ in human Sertoli cells [157]. Treatment
with anti-inflammatory agents suppress this cell death
pathway thereby validating the involvement of PARP in
inflammatory responses [158,159]. It remains to be seen
if this anti-inflammatory activity of PARP could also be
applied to germ cells.
PARP and spermatogenesis
PARP1 has been detected in the nuclei of a variety of tissue
types including the brain, heart, kidney, and testis [121].
PARP2 has been detected in the liver, kidney, spleen, adre-
nal gland, stomach, intestinal epithelium, thymus, brain
tissue, and testis. PARP2 expression is weaker than that of
PARP1 and is well distinguished [51]. PARP1 has high lev-
els of expression in the basal regions of seminiferous
tubules of developing mice, but has almost no presence in
the luminal region of the seminiferous tubules, suggesting
that PARP1 is down-regulated during the haploid stage of
meiosis [51]. This explains why PARP is expressed signifi-
cantly during the earlier stages of spermatogenesis. How-
ever other reports show that in the rat, the highest
concentrations of PARP1 are seen in primary spermato-
cytes followed by spermatids as transcription declines in
late stages on maturation [160,161]. In a study by Tra-
montano et al examining rat primary spermatocytes it was
found that both PARP1 and PARP2 are present in these
germ cells. However, the vast majority of PAR in these rat
primary spermatocytes was produced by PARP1 suggest-
ing possibly different roles of PARP1 and PARP2 in sper-
matogenesis [107]. Interestingly, PARG has also been
detected in the nuclei of rat primary spermatocytes [160]
suggesting the presence of a mechanism to regulate the
levels of poly (ADP-ribose) in germ cells.
In a recent study using human testicular samples, it was
shown that that the strongest levels of PARP1 were found
in spermatogonia. Presence of poly (ADP-ribose) differed
slightly with the stage of spermatogenesis. Poly (ADP-
ribosyl)ation was strongest in human round and elongat-
ing spermatids as well as in a subpopulation of primary
spermatocytes. In contrast, mature spermatids had no
PARP expression or poly (ADP-ribosyl)ation [153]. This is
in accordance with a study in rat germ cells where poly
(ADP-ribose) and NAD levels progressively decreased
from primary to secondary spermatocytes and to a greater
extent in spermatids [74]. This decrease in PARP1 levels
and activity throughout differentiating male germ cells
may be correlated with the changes in chromatin structure
associated with spermatogenesis. The chromatin remode-
ling steps of spermatogenesis include the replacement of
histones by protamines [162] and a transition from a
supercoiled form of DNA to a non-supercoiled form
[163]. It is during these chromatin remodeling steps of
spermiogenesis that DNA strand breaks can occur. In
human testis, an increase in DNA strand breaks occurs in
100% of elongating spermatids [164]. These breaks were
later demonstrated to be double stranded breaks caused
by topoisomerase II as a result of the unique chromatin
packaging steps that take place during spermatogenesis
[14].Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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Meyer-Ficca et al (2005) demonstrated the presence of
poly (ADP-ribose) (PAR) in elongated spermatids of rat
[39]. They showed that during these steps when a high
number of DNA breaks occur directly preceding nuclear
condensation, there is correspondingly a higher amount
of PAR in rat germ cells. Greater PAR formation through
PARP1 and PARP2 action occurs during this phase of sper-
matogenesis that includes a great deal of chromatin con-
densation (steps 11-14 of rat spermatogenesis), PAR levels
decrease only when protamines appear in the chromatin.
Thus, PAR formation could be important for repairing
DNA strand breaks during these crucial chromatin remod-
eling steps of spermatogenesis [39,165]. Furthermore,
PAR formation could also be important for histone mod-
ification because not only is there auto-modification of
PARP during spermatogenesis, but much of PARP activity
is targeted towards the testes-specific histone, H1t.
The activation of Histone 2A (H2AX), a biological marker
of DNA breaks, and the poly (ADP-ribose)ylation of his-
tones at break sites may act as markers of such damage
[166]. Thus, the activity of PARP during the chromatin
remodeling steps of spermatogenesis in terms of repairing
double stranded breaks and the poly (ADP-ribosyl)ation
of histones, is critical and disregulation of the chromatin
remodeling steps of spermiogenesis could have serious
consequences for the male gamete [164]. PARP2 knock-
out mouse was shown to be associated with severely com-
promised spermatids and delays in elongation process
[154]. Heat stress has been reported to decrease PARP
expression in the rat testis [50]. However heat shock pro-
tein was reported to activate the PARP and PAR formation
[92].
The quest to detect PARP in ejaculated spermatozoa has
met with success only recently. Taylor et al did not detect
the presence of PARP1 in human ejaculated sperm sam-
ples when analyzing semen for apoptotic markers [167].
However, in a recent study by Jha et al, [168] several iso-
forms of PARP were detected in ejaculated spermatozoa
including PARP1, PARP2, and PARP9. Immunolocaliza-
tion patterns showed that PARP was found near the acro-
somal regions in sperm heads. Furthermore, a direct
correlation was seen between sperm maturity and the
presence of PARP, i.e., an increased presence of PARP1,
PARP2, and PARP9 was seen in mature sperm when com-
pared to immature sperm. Higher levels of PARP1, PARP2
and PARP9 were seen in ejaculated sperm from fertile
men when compared to infertile men indicating a possi-
ble relationship between PARP and male infertility. PARP
activity was modulated to determine its role in the
response to oxidative and chemical damage in sperm. In
the presence of a PARP inhibitor, 3-aminobenzamide,
chemical and oxidative stress-induced apoptosis was
reported to increase by nearly two-fold. This novel finding
suggests that PARP could play an important role in pro-
tecting spermatozoa subjected to oxidative and chemical
damage [168].
PARP and sperm DNA
Recently the importance of DNA damage to sperm of
infertile men has gained attention. It has been shown that
that a higher index of DNA damage can possibly lead to
lower semen quality. In a study involving 322 couples,
when DNA fragmentation exceeded an index of 15%,
there was increased incidence of non-transfer and miscar-
riages after performing ICSI [169]. Studies such as these
warrant the investigation of factors that may be responsi-
ble for maintaining genomic integrity especially in ejacu-
lated spermatozoa. DNA damage repair through PARP
activity has been demonstrated in rat germ cells. Atorino
et al showed that after extensive DNA damage in rat sper-
matids and spermatocytes caused by radiation and ROS
damage in vivo, a PARP inhibitor caused a delay in DNA
damage repair [40]. They were able to demonstrate up to
a 3-fold increase in PARP activation as cells recovered
from these damaging agents [60,125,126]. The main dif-
ference between spermatids and primary spermatocytes
was that only spermatids showed detectable PAR produc-
tion after genotoxic stress. Atorino et al hypothesized that
primary spermatocytes did not show the same degree of
response possibly due to the different chromatin states of
these two germ cells. Thus, PARP activity in response to
genotoxic stress may be important for preventing muta-
tions from accumulating and being passed on to offspring
[40].
Though the role of PARP in repairing DNA damage in
ejaculated spermatozoa has yet to be thoroughly investi-
gated, it has been found that DNA damage caused by
sperm cryopreservation can be repaired through PARP
activity. In a study by Kopeika et al, cryopreserved sperm
from loach (fresh water fish related to carp) were used to
fertilize eggs and the embryos were exposed to a PARP
inhibitor [170]. It was found that survival was signifi-
cantly decreased in embryos exposed to PARP inhibitors
when compared to control. This study suggests a possible
role for PARP in repairing paternal DNA damage and it
also showed that it was possible for the oocyte to repair
this damage even in presence of PARP inhibition [170].
Cryopreservation is not the only threat to genomic integ-
rity. It is still controversial whether malignancy itself is the
cause of chromatin damage in mature spermatozoa. In a
study analyzing 75 men with various types of testicular
and non-testicular cancers, the degree of DNA fragmenta-
tion did not differ between types of cancer. But surpris-
ingly, the levels of DNA fragmentation in cancer patients
were similar to the levels found in infertile men [171].
Another study found that patients with testicular cancerReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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and Hodgkin's Lymphoma were normospermic, but had
increased levels of DNA damage along with decreased
chromatin compaction [172]. However, a third study in
the same year hypothesized that malignancy alone was
not responsible for increased DNA damage seen in sperm.
This study showed that thawed sperm samples from can-
cer patients had similar levels of DNA fragmentation to
that of sperm with low freezability collected from healthy
donors. This study attributed the increased sperm DNA
damage seen in the decreased freezability of these semen
specimens and not to malignancy [173].
Nonetheless, cancer patients are advised to freeze sperm
prior to therapy as an option to preserve their fertility
potential. Patients undergoing radiotherapy have shown a
temporary increase in the sperm with DNA strand breaks
and a decrease in fertility despite having normal sperm
concentrations [42]. Chemotherapy does not produce the
same deleterious effects as radiotherapy in its initial
phase. Decrease in sperm DNA fragmentation is generally
seen after 3 or more cycles of chemotherapy [174]. Chem-
otherapy (especially alkylating agents) and radiotherapy,
even in low doses, can damage the seminiferous epithe-
lium and impair spermatogenesis in both children and
adults [175].
Apart from treatment by either chemo- or radiotherapy,
malignancy itself causes a significant threat to sperm DNA
damage. This could mean that cryopreservation of sperm
prior to therapy may not be sufficient to preserve fertility
[174]. Instead, therapeutic options such as modification
of PARP activity could be used in order to retain genomic
integrity under threats of malignancy and radiotherapy to
eliminate the low quality spermatozoa with DNA damage
[176,177].
Sperm DNA damage repair defects
DNA polymerase activity in non-replicating cells is associ-
ated with DNA repair. Consequently, increase in apop-
totic markers seen in the semen of infertile men may also
be an indicator of increase DNA repair activity [15]. Evi-
dence from the literature indicates that DNA repair sys-
tems may play a role during spermiogenesis. Elements of
base excision repair (BER) have been identified in elon-
gated spermatids [178]. Mismatch repair (MMR) involv-
ing the mutS homolog 2 (MSH2) proteins has a role in
spermiogenesis. Interestingly, in a mouse model for Hunt-
ington disease, deletion of MSH2 in Huntington disease
abolished trinucleotide cytosine-adenine-guanisine
(CAG) repeat expansion between round spermatids and
spermatozoa. CAG, is a DNA mutation responsible for
causing any type of disorder categorized as a trinucleotide
repeat disorder. Presence of CAG repeat expansion may
explain the earlier onset of the disease and the severity of
the symptoms through successive generations of an
affected family due to the expansion of these repeats.
Deletion of MSH2 suggests an active role for MSH2 during
extensive DNA repair [179-182]. Quite interestingly, caf-
feine may lead to inactivation of H2AX and non-homolo-
gous end-joining (NHEJ) DNA repair [183]. Impairment
in DNA repair during spermiogenesis may result in per-
sistent double stranded breaks in mature spermatozoa.
Further investigation may provide important clues regard-
ing the consequences of the endogenous DNA strand
breaks and repair in spermatids and mature spermatozoa
[184].
Down regulation of DNA repair genes such as Ogg1
(involved in base excision repair), Rad54 (involved in
double-strand break repair) and Xpg (involved in nucle-
otide excision repair) has been reported using global
genome expression by DNA microarray following expo-
sure to heat stress at 43°C [30]. Heat stress induced by
cryptorchidism appears to result in decreased expression
of DNA polymerase B and DNA ligase III both of which
are involved in the final stages of DNA repair [185,186].
PARP - a new marker in ejaculated spermatozoa
The role of PARP in DNA repair (Figure 2) and its presence
during stages of spermatogenesis suggest that it is
involved in maintaining genomic integrity in ejaculated
sperm. However, the presence of PARP has only recently
been shown in ejaculated sperm samples. Furthermore,
Jha et al have suggested a correlation with the presence of
PARP and male fertility [168]. This study suggested that
the decreased presence of PARP in the sperm of infertile
men could be the cause of increased DNA damage seen in
poor quality semen samples. DNA damage repair in germ
cells as mediated by PARP is therefore as yet unexplored
confounder of male fertility. Further studies are needed to
fully explore the role of PARP in DNA repair especially in
reproductive medicine [50-52,55,187]. The existing meth-
ods of detecting infertility from semen samples are quan-
titative methods involving the count and observation of
sperm and are dubious due to the constantly changing
'normal' seminal values. A qualitative method would thus
serve as a more reliable method of detecting infertility
[125,162]. In view of this, the detection of apoptotic
markers such as caspase and phosphatidylserine (PS) have
been successfully correlated with a variety of infertility
conditions; however, the use of PARP as an apoptotic
marker has not been fully investigated.
Taylor et al found greater caspase activity in low motility
sperm samples from infertile men when compared to
those with high motility [167]. The active caspase
enzymes have been localized in the human spermatozoa
predominantly in the post acrosomal region (caspase 8, 1
and 3) [188-190] or in the mid-piece [191]. A significant
positive correlation between in-situ active caspase-3 in theReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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sperm midpiece and DNA fragmentation was observed in
the low motility fractions of patients, suggesting that cas-
pase-dependent apoptotic mechanisms could originate in
the cytoplasmic droplet or within mitochondria and func-
tion in the nucleus [192]. These data suggest that in some
ejaculated sperm populations, caspases are present and
may function to increase PS translocation and DNA frag-
mentation. Furthermore fluorescence staining of active
caspases localized the enzymes mainly to the postacro-
somal region in sperm from donors. This pattern differed
slightly from that of patients, in whom additional cyto-
plasmic residues were found to be highly positive [193].
In an interesting study published by Falerio and Lazebnik
in 2000, question as to how caspase 3 which is usually
cytoplasmic gains access to its nuclear targets was exam-
ined [194]. These investigators suggested that caspase-3
was actively transported to the nucleus through the
nuclear pores. They found that caspase-9, which is acti-
vated earlier than caspase-3, directly or indirectly inacti-
vated nuclear transport and increased the diffusion limit
of the nuclear pores. This increase allowed caspase-3 and
other molecules that could not pass through the nuclear
pores in living cells to enter or leave the nucleus during
apoptosis by diffusion. Hence they suggested that caspase-
9 contributes to cell disassembly by disrupting the nuclear
cytoplasmic barrier [194].
Unlike somatic cells, early studies were not able to detect
PARP1 or AIF (which is activated by PARP) in ejaculated
sperm [106,167,195,196]. Similarly, the presence of
cleaved PARP could not be detected in ejaculated sperm
[197]; although PARP activity was demonstrated in the
testis [198]. We studied the localization of the PARP in
mature and immature spermatozoa in fertile and infertile
men [168]. Mahfouz et al were the first to demonstrate the
presence of cleaved PARP in ejaculated spermatozoa.
When these sperm samples were exposed to PARP inhibi-
tors after chemical and oxidative stress, there was a
decreased incidence of apoptosis [199]. Although these
authors did not study PARP and caspase 3 co-localization,
they proposed that PARP cleavage may occur by activated
caspase 3 located in the post acrosomal region. It would
be worthwhile to replicate these findings in other mam-
mals and investigate the use of cleaved PARP as a diagnos-
tic tool to predict/detect male infertility.
PARP and oxidative stress
Oxidative stress (OS) occurs when there is an increase in
ROS levels and/or a decrease in the activity of the antioxi-
dant enzymes that scavenge these harmful free radicals
[200,201]. Such conditions of oxidative stress arise when
germ cells are faced with biological (such as lipopolysac-
charide, LPS) or chemical stressors (e.g. environmental
toxicants, endocrine disruptors etc.) [20,31,202-204]. The
extent of oxidative stress induced depends on the dose
and duration of exposure to the stressor [204]. Oxidative
stress can cause modification of proteins associated with
developing spermatozoa and cause the premature release
of sperm from seminiferous tubules [205]. Even a tran-
sient state of oxidative stress, spanning a few hours has
been shown to bring about protein changes and stimulate
a caspase-3-mediated cell death pathway and apoptosis
[43,206]. In the reproductive milieu, oxidative stress is
also linked to inflammation particularly since inflamma-
tory cytokines dramatically arrest spermatogenesis and
may lead to infertility [207]. However, the most impor-
tant effect is the ability of oxidative stress to cause DNA
damage. PARP responds to all three of these changes that
can occur in the cell as a result of oxidative damage. How-
ever, there is a great deal of variability in PARP activation
as a result of this type of stress depending on the meta-
bolic stage of the cell or its microenvironment [208-210].
As a result of its interaction with NF-κβ, PARP has an
important role in the inflammation process [78,102]. In
response to DNA damage caused by oxidative species,
PARP1 recruits the DNA repair protein XRCC1 to the sites
of the damage [211]. In addition to causing damage to
DNA, oxidative species can harm histones wherein PARP
activates the 20S proteosome involved in breaking down
oxidatively damaged histones. Also, in response to oxida-
tive stress caused by exposure of histones to hydrogen per-
oxide, a complex is formed by the binding of PARP, poly
(ADP-ribose), and the nuclear proteosome [133,212].
This complex formation could be important because a
condensed chromatin structure may protect DNA from
strand breaks induced by hydroxyl radicals [196,213].
In conditions of oxidative stress-induced necrosis in Bax-/
- Bak-/- (a proapoptotic protein that regulates the intrinsic
apoptotic pathway) mouse embryonic fibroblasts, there is
an activation of PARP1. PARP1-catalysed poly (ADP-ribo-
syl)ation causes a depletion of ATP, which promotes the
autophagy of these necrotic embryonic cells [214]. PARP1
has been implicated in the repair of DNA damaged by
estradiol in human estrogen-receptor-negative (ER-/-)
breast cancer cells. Treatment of these breast cancer cells
with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which
is itself an estrogenic toxicant, altered the expression of
enzymes responsible for the bio-activation of estrogen
leading to DNA damage, PARP1 activation and DNA
repair. Thus, the apoptosis of human ER -/breast cancer
cells was prevented by TCDD-induced activation of
PARP1 and aided the survival of these cancer cells [215].
Interestingly, administration of TCDD caused the expres-
sion of cDNA encoding a 75 kDa protein that had
sequence similarity with PARP. This protein, renamed as
TCDD-inducible PARP (TiPARP) possessed catalytic activ-
ity similar to PARP [216]. However, the role of TiPARP onReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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chromosome stability, DNA repair and apoptosis are yet
to be elucidated.
PARP and ageing
The ageing process also takes its toll on DNA, which can
in turn, affect the fertility potential of a male. As discussed
earlier, PARP is also involved in ageing through its role in
immune responses, telomere maintenance, DNA repair,
spindle assembly, and cell death [217]. In a recent study,
El-Domyati et al collected sperm samples from fertile men
of various age groups and quantified the differences in
PARP1 presence and PARP activity [198]. The expression
of PARP1 and its DNA repair partner, XRCC1 were higher
in spermatocytes of older men while the Sertoli cells of
these men showed higher levels of PAR. Apoptosis was
increased in older men who showed more active caspase-
3 and cleaved PARP1 in the spermatogonia and spermato-
cytes. This general increase in PARP1 and DNA repair
enzymes could be associated with the declining DNA
integrity as a result of age [198].
Chromosomal stability is vital for the survival of an
organism and chromosomal instability increases with the
age of an organism and is considered a symptom of age-
ing. PARP is essential for chromosomal stability through
its role in DNA repair. PARP activity may influence ageing
by maintaining genomic stability through DNA repair, tel-
omere maintenance, spindle stability, and cell death
[209,217-219]. Under physiological conditions, both
PARP1 and PARP2 affect telomere functioning by binding
to telomere repeat binding factor II (TRFII) and affecting
its ability to bind to telomere regions [220-222]. PARP1 is
also found at telomere regions of DNA that is damaged by
genotoxic agents and it may play a role in preventing dam-
age to genomic stability [221]. PARP1 deficient mice
showed greater incidence of chromosomal aberrations,
polyploidy and telomere shortening. When PARP was
reintroduced in the form of cDNA, chromosomal integrity
was restored [223,224].
Biological role of PARP in male fertility
PARP plays a crucial role in maintaining genomic integrity
in a variety of cell types and perhaps nowhere is this
genomic integrity more important than in germ cells.
Cases of male infertility are associated with abnormal
sperm chromatin and DNA structure. The problems that
arise in genomic integrity of sperm come from a variety of
sources including spermatogenesis defects, abortive apop-
tosis, problems with spermatid maturation, and oxidative
stress [22,225]. Problems in spermatogenesis could
include double strand breaks that are not resolved after
crossing over during meiosis I [22]. Although there has
not been any clear association between apoptotic markers
and DNA fragmentation in mature male gametes, it is pos-
sible that incomplete apoptosis could be a cause of such
DNA fragmentation [22,226]. Maturation of spermatids
involves chromatin remodeling steps that involve neces-
sary DNA strand breaks and thus could be a source of
unresolved breaks. Lastly, ROS levels and oxidative stress
has been extensively investigated in male infertility, and
in light of the activation of PARP-induced apoptosis path-
ways in oxidative stress conditions, may provide an expla-
nation for the role of PARP in male fertility.
Thus, at the time of writing this review, the role of PARP
in male fertility is not as well defined as its role in other
cellular processes. However, there is enough evidence
such as detection of PARP in the testis, during sperma-
togenesis, and in ejaculated spermatozoa to suggest that
such a role exists [168,199]. Furthermore, the role of
PARP as an important DNA repair enzyme could
empower it with maintaining the genomic integrity of
sperm. Similarly, the role of PARP in cell death pathways
may have important implications for its role in the elimi-
nation of abnormal spermatozoa during the processes of
spermatogenesis [227].
Potential therapeutic applications of PARP
The key role of PARP in cell death has made it an attractive
candidate in cancer therapies [157]. It is based on the sim-
ple idea that inhibiting DNA repair in malignant cells
exposed to chemotherapy will kill off these cancerous
cells due to the large amounts of DNA damage that will
accumulate if PARP is inactivated [228]. Non-malignant
cells will not be susceptible to cell death at these low doses
of chemotherapy. Thus PARP inhibitors could provide a
means to sensitize cancerous cells to chemotherapy and
be developed as an adjuvant to chemotherapy [229]. An
alternate strategy being explored is that of inactivating
PARP through cleavage to attain the same end result, i.e.,
accumulation of damaged DNA in cancerous cells causing
them to die faster [227,230].
PARP modulation may not only prove useful in cancer
therapies, but also in dangerous inflammatory processes.
The role of PARP in inflammation especially through the
recruitment of NF-κβ and through its role in responding
to oxidative stress produced by the inflammatory proc-
esses make it a powerful target for anti-inflammatory ther-
apy [157]. The use of PARP inhibitors as therapeutics in
conditions such as cerebral ischemia and other inflamma-
tion-induced conditions may be explored [159,219]. It
still remains to be seen whether PARP can provide a ther-
apy for male infertility. PARP inhibition may protect
against chemically induced injury of ejaculated spermato-
zoa in vitro, but is not effective against damage induced
by oxidative stress [199]. It is also possible that PARP inhi-
bition may have a potential role in testicular cancer as well
as cancer that may have spread to the testes [109]. Inflam-
matory processes as result of infections could also beReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
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another area to explore in terms of PARP and male fertil-
ity.
Conclusion
PARP homologues have diverse role(s) in spermatogene-
sis and in ejaculated sperm. PARP expression is associated
with sperm maturity in proven fertile men. Morphogene-
sis and changes during the spermatid stages result in
removal of the cytoplasm from the fully mature, function-
ally active spermatozoa. However, many proteomic stud-
ies, other than those published by our group (Jha et al
2009) have shown differences in protein expression in
spermatozoa from infertile males. Although the mature
spermatozoa are transcriptionally inactive, some reports
suggest that there may be enough mRNA in these mature
spermatozoa, although their exact function and role is
unclear and is being investigated. PARP inhibition may be
used as an in vitro treatment in certain conditions such as
oxidative stress and/or chemically induced death of sper-
matozoa with damaged DNA. Therefore these spermato-
zoa may not have the ability to fertilize or produce
healthy embryo as the oocyte repair system may be inad-
equate to correct such high DNA damage. PARP modula-
tion using kinase activators or inhibitors may have a
future beneficial role in infertile patients exhibiting sperm
DNA damage. This could pave the way for future studies
to elucidate the role of PARP in other conditions resulting
in sperm DNA damage. Cleaved PARP, which is activated
during apoptosis, could serve as an apoptotic marker for
differentiating healthy spermatozoa from apoptotic ones.
In addition, the anti-tumor properties of PARP could pro-
vide new strategies to preserve fertility in cancer patients
even after genotoxic stresses like radiation. The possibility
of using DNA damaged sperm in ART especially in ICSI
needs careful evaluation. PARP may hold the key to a bet-
ter understanding of these repair mechanisms inherent in
spermatozoa and the importance of such mechanisms in
producing healthy pregnancies.
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joining; NLS: Nuclear localization signal; PAR: Poly (ADP-
ribose); PARG: Poly (ADP-ribose) glycohydrolase; PARP:
Poly (ADP-ribose) polymerase; Rad54: A gene linked to
chromosome 1p32, encodes for a protein known to be
involved in the homologous recombination and repair of
DNA; ROS: Reactive oxygen species; SCOS: Sertoli cell
only syndrome; SIRT1: Silent information regulator gene
in human affect the metabolism and inflammation; TBP:
TATA-binding protein; TCDD: 2, 3, 7, 8-tetrachlorod-
ibenzo-p-dioxin; TRFI-I: Telomere repeat binding factor
II, I; WWE domains, Domain associated with protein-pro-
tein interaction; XRCC1: X-ray repair complementing
defective repair in Chinese hamster cells 1; YY1:
YinYang1.
Competing interests
No financial competing interests (political, personal, reli-
gious, ideological, academic, intellectual, commercial or
any other) to declare in relation to this paper.
Authors' contributions
AA provided substantial contribution ranging from study
idea, design, information collection, critical review of the
final paper. RZM participated in the original idea,
medline search, drafting and finalizing the paper. RKS
conceived the study, participated in the study design com-
pilation of the contents and critical review of the paper.
OS participated in compilation of the information and
critical review of the paper. DM carried out the literature
search, compilation of the information. PPM participated
in the design of the study and helped finalize the paper.
All authors read and approved the final manuscript.
Acknowledgements
Authors are grateful for the support from the Center for Reproductive 
Medicine, Cleveland Clinic.
References
1. Ogawa T, Ito C, Nakamura T, Tamura Y, Yamamoto T, Noda T,
Kubota Y, Toshimori K: Abnormal sperm morphology caused
by defects in Sertoli cells of Cnot7 knockout mice.  Archives of
histology and cytology 2004, 67(4):307-314.
2. Suzuki-Toyota F, Ito C, Toyama Y, Maekawa M, Yao R, Noda T, Iida
H, Toshimori K: Factors maintaining normal sperm tail struc-
ture during epididymal maturation studied in Gopc-/- mice.
Biol Reprod 2007, 77(1):71-82.
3. Toshimori K, Ito C, Maekawa M, Toyama Y, Suzuki-Toyota F, Saxena
DK:  Impairment of spermatogenesis leading to infertility.
Anatomical science international/Japanese Association of Anatomists 2004,
79(3):101-111.
4. Aitken RJ, De Iuliis GN: Origins and consequences of DNA dam-
age in male germ cells.  Reproductive biomedicine online 2007,
14(6):727-733.
5. Amiri I, Sheikh N, Najafi R: Nitric oxide level in seminal plasma
and its relation with sperm DNA damages.  Iran Biomed J 2007,
11(4):259-264.
6. Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-
Vaknin N, Moreno-Villanueva M, Burkle A, Markovitz DM, Ferrando-
May E: DEK is a poly(ADP-ribose) acceptor in apoptosis andReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 15 of 20
(page number not for citation purposes)
mediates resistance to genotoxic stress.  Mol Cell Biol 2008,
28(10):3245-3257.
7. Tripathi DN, Jena GB: Astaxanthin inhibits cytotoxic and geno-
toxic effects of cyclophosphamide in mice germ cells.  Toxicol-
ogy 2008, 248(2-3):96-103.
8. Sakkas D, Moffatt O, Manicardi GC, Mariethoz E, Tarozzi N, Bizzaro
D: Nature of DNA damage in ejaculated human spermato-
zoa and the possible involvement of apoptosis.  Biol Reprod
2002, 66(4):1061-1067.
9. Patrizio P, Sanguineti F, Sakkas D: Modern andrology: from
semen analysis to postgenomic studies of the male gametes.
Annals of the New York Academy of Sciences 2008, 1127:59-63.
10. Seli E, Sakkas D: Spermatozoal nuclear determinants of repro-
ductive outcome: implications for ART.  Human reproduction
update 2005, 11(4):337-349.
11. Tesarik J, Mendoza-Tesarik R, Mendoza C: Sperm nuclear DNA
damage: update on the mechanism, diagnosis and treat-
ment.  Reproductive biomedicine online 2006, 12(6):715-721.
12. El-Domyati MM, Al-Din AB, Barakat MT, El-Fakahany HM, Honig S,
Xu J, Sakkas D: The expression and distribution of deoxyribo-
nucleic acid repair and apoptosis markers in testicular germ
cells of infertile varicocele patients resembles that of old fer-
tile men.  Fertility and sterility 2008 in press.
13. Laberge RM, Boissonneault G: Chromatin remodeling in sper-
matids: a sensitive step for the genetic integrity of the male
gamete.  Arch Androl 2005, 51(2):125-133.
14. Laberge RM, Boissonneault G: On the nature and origin of DNA
strand breaks in elongating spermatids.  Biol Reprod 2005,
73(2):289-296.
15. Leduc F, Nkoma GB, Boissonneault G: Spermiogenesis and DNA
repair: a possible etiology of human infertility and genetic
disorders.  Systems biology in reproductive medicine 2008, 54(1):3-10.
16. Sharma RK, Said T, Agarwal A: Sperm DNA damage and its clin-
ical relevance in assessing reproductive outcome.  Asian journal
of andrology 2004, 6(2):139-148.
17. Agarwal A, Said TM: Carnitines and male infertility.  Reproductive
biomedicine online 2004, 8(4):376-384.
18. Agarwal A, Ranganathan P, Kattal N, Pasqualotto F, Hallak J, Khayal S,
Mascha E: Fertility after cancer: a prospective review of
assisted reproductive outcome with banked semen speci-
mens.  Fertil Steril 2004, 81(2):342-348.
19. Agarwal A, Allamaneni SS: Sperm DNA damage assessment: a
test whose time has come.  Fertil Steril 2005, 84(4):850-853.
20. Agarwal A, Said TM: Oxidative stress, DNA damage and apop-
tosis in male infertility: a clinical approach.  BJU international
2005, 95(4):503-507.
21. Bungum M, Humaidan P, Axmon A, Spano M, Bungum L, Erenpreiss J,
Giwercman A: Sperm DNA integrity assessment in prediction
of assisted reproduction technology outcome.  Hum Reprod
2007, 22(1):174-179.
22. Erenpreiss J, Spano M, Erenpreisa J, Bungum M, Giwercman A:
Sperm chromatin structure and male fertility: biological and
clinical aspects.  Asian J Androl 2006, 8(1):11-29.
23. Muratori M, Luconi M, Marchiani S, Forti G, Baldi E: Molecular
markers of human sperm functions.  International journal of
andrology 2009, 32(1):25-45.
24. Lewis SE, Aitken RJ: DNA damage to spermatozoa has impacts
on fertilization and pregnancy.  Cell Tissue Res 2005,
322(1):33-41.
25. Tremellen K: Oxidative stress and male infertility--a clinical
perspective.  Human reproduction update 2008, 14(3):243-258.
26. Schmid TE, Eskenazi B, Baumgartner A, Marchetti F, Young S, Weldon
R, Anderson D, Wyrobek AJ: The effects of male age on sperm
DNA damage in healthy non-smokers.  Hum Reprod 2007,
22(1):180-187.
27. Chitra KC, Latchoumycandane C, Mathur PP: Effect of nonylphe-
nol on the antioxidant system in epididymal sperm of rats.
Arch Toxicol 2002, 76(9):545-551.
28. Mathur P, Saradha B, Vaithinathan S: Impact of environmental
toxicants on testicular function.  Immun Endoc Metab Agents Med
Chem 2008, 8:79-90.
29. Olsen AK, Lindeman B, Wiger R, Duale N, Brunborg G: How do
male germ cells handle DNA damage?  Toxicol Appl Pharmacol
2005, 207(2 Suppl):521-531.
30. Rockett JC, Mapp FL, Garges JB, Luft JC, Mori C, Dix DJ: Effects of
hyperthermia on spermatogenesis, apoptosis, gene expres-
sion, and fertility in adult male mice.  Biol Reprod 2001,
65(1):229-239.
31. Saradha B, Mathur P: Effect of environmental contaminants on
male reproduction.  Environ Toxicol Pharmacol 2006, 21:34-41.
32. Desai N, Sabanegh E Jr, Kim T, Agarwal A: Free Radical Theory of
Aging: Implications in Male Infertility.  Urology 2009 in press.
33. Agarwal A, Desai NR, Ruffoli R, Carpi A: Lifestyle and testicular
dysfunction: a brief update.  Biomed Pharmacother 2008,
62(8):550-553.
34. Gero D, Szabo C: Poly(ADP-ribose) polymerase: a new thera-
peutic target?  Curr Opin Anaesthesiol 2008, 21(2):111-121.
35. Gagne JP, Moreel X, Gagne P, Labelle Y, Droit A, Chevalier-Pare M,
Bourassa S, McDonald D, Hendzel MJ, Prigent C, Poirier GG: Pro-
teomic Investigation of Phosphorylation Sites in Poly(ADP-
ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase.
J Proteome Res 2009, 8(2):1014-1029.
36. Reed AM, Fishel ML, Kelley MR: Small-molecule inhibitors of
proteins involved in base excision repair potentiate the anti-
tumorigenic effect of existing chemotherapeutics and irradi-
ation.  Future Oncology 2009, 5(5):713-726.
37. Di Meglio S, Tramontano F, Cimmino G, Jones R, Quesada P: Dual
role for poly(ADP-ribose)polymerase-1 and -2 and
poly(ADP-ribose)glycohydrolase as DNA-repair and pro-
apoptotic factors in rat germinal cells exposed to nitric oxide
donors.  Biochim Biophys Acta 2004, 1692(1):35-44.
38. Sinha Hikim AP, Lue Y, Diaz-Romero M, Yen PH, Wang C, Swerdloff
RS: Deciphering the pathways of germ cell apoptosis in the
testis.  J Steroid Biochem Mol Biol 2003, 85(2-5):175-182.
39. Meyer-Ficca ML, Scherthan H, Burkle A, Meyer RG: Poly(ADP-
ribosyl)ation during chromatin remodeling steps in rat sper-
miogenesis.  Chromosoma 2005, 114(1):67-74.
40. Atorino L, Di Meglio S, Farina B, Jones R, Quesada P: Rat germinal
cells require PARP for repair of DNA damage induced by
gamma-irradiation and H2O2 treatment.  Eur J Cell Biol 2001,
80(3):222-229.
41. Sakkas D, Mariethoz E, Manicardi G, Bizzaro D, Bianchi PG, Bianchi U:
Origin of DNA damage in ejaculated human spermatozoa.
Rev Reprod 1999, 4(1):31-37.
42. Stahl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Stahl E,
Giwercman A: Sperm DNA integrity in testicular cancer
patients.  Hum Reprod 2006, 21(12):3199-3205.
43. Mahfouz RZ, Sharma RK, Said TM, Erenpreiss J, Agarwal A: Associa-
tion of sperm apoptosis and DNA ploidy with sperm chro-
matin quality in human spermatozoa.  Fertility and sterility 2009,
91(4):1110-1118.
44. Lewis SE: Is sperm evaluation useful in predicting human fer-
tility?  Reproduction 2007, 134(1):31-40.
45. Zini A, Boman JM, Belzile E, Ciampi A: Sperm DNA damage is
associated with an increased risk of pregnancy loss after IVF
and ICSI: systematic review and meta-analysis.  Hum Reprod
2008, 23(12):2663-2668.
46. Horak S, Olejek A, Widlak P: Sperm DNA adducts impair ferti-
lization during ICSI but not during IVF.  Folia Histochem Cytobiol
2007, 45(Suppl 1):S99-104.
47. Li Z, Wang L, Cai J, Huang H: Correlation of sperm DNA dam-
age with IVF and ICSI outcomes: a systematic review and
meta-analysis.  J Assist Reprod Genet 2006, 23(9-10):367-376.
48. Nasr-Esfahani MH, Salehi M, Razavi S, Anjomshoa M, Rozbahani S,
Moulavi F, Mardani M: Effect of sperm DNA damage and sperm
protamine deficiency on fertilization and embryo develop-
ment post-ICSI.  Reproductive biomedicine online 2005,
11(2):198-205.
49. Niederberger C: Efficient treatment of infertility due to sperm
DNA damage by ICSI with testicular spermatozoa.  J Urol
2005, 174(3):1048.
50. Paul C, Melton DW, Saunders PT: Do heat stress and deficits in
DNA repair pathways have a negative impact on male fertil-
ity?  Mol Hum Reprod 2008, 14(1):1-8.
51. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V, Menis-
sier-de Murcia J, de Murcia G: Poly(ADP-ribose) polymerase-2
(PARP-2) is required for efficient base excision DNA repair
in association with PARP-1 and XRCC1.  J Biol Chem 2002,
277(25):23028-23036.
52. Flohr C, Burkle A, Radicella JP, Epe B: Poly(ADP-ribosyl)ation
accelerates DNA repair in a pathway dependent onReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 16 of 20
(page number not for citation purposes)
Cockayne syndrome B protein.  Nucleic Acids Res 2003,
31(18):5332-5337.
53. Ame JC, Spenlehauer C, de Murcia G: The PARP superfamily.
Bioessays 2004, 26(8):882-893.
54. Hassa PO, Hottiger MO: The diverse biological roles of mam-
malian PARPS, a small but powerful family of poly-ADP-
ribose polymerases.  Front Biosci 2008, 13:3046-3082.
55. Wacker DA, Frizzell KM, Zhang T, Kraus WL: Regulation of chro-
matin structure and chromatin-dependent transcription by
poly(ADP-ribose) polymerase-1: possible targets for drug-
based therapies.  Subcell Biochem 2007, 41:45-69.
56. Schreiber V, Dantzer F, Ame JC, de Murcia G: Poly(ADP-ribose):
novel functions for an old molecule.  Nat Rev Mol Cell Biol 2006,
7(7):517-528.
57. Augustin A, Spenlehauer C, Dumond H, Menissier-De Murcia J, Piel
M, Schmit AC, Apiou F, Vonesch JL, Kock M, Bornens M, De Murcia
G: PARP-3 localizes preferentially to the daughter centriole
and interferes with the G1/S cell cycle progression.  J Cell Sci
2003, 116(Pt 8):1551-1562.
58. Baumgartner M, Schneider R, Auer B, Herzog H, Schweiger M, Hir-
sch-Kauffmann M: Fluorescence in situ mapping of the human
nuclear NAD+ ADP-ribosyltransferase gene (ADPRT) and
two secondary sites to human chromosomal bands 1q42,
13q34, and 14q24.  Cytogenet Cell Genet 1992, 61(3):172-174.
59. Cherney BW, McBride OW, Chen DF, Alkhatib H, Bhatia K, Hensley
P, Smulson ME: cDNA sequence, protein structure, and chro-
mosomal location of the human gene for poly(ADP-ribose)
polymerase.  Proc Natl Acad Sci USA 1987, 84(23):8370-8374.
60. Woodhouse BC, Dianova II, Parsons JL, Dianov GL: Poly(ADP-
ribose) polymerase-1 modulates DNA repair capacity and
prevents formation of DNA double strand breaks.  DNA Repair
(Amst) 2008, 7(6):932-940.
61. D'Amours D, Desnoyers S, D'Silva I, Poirier GG: Poly(ADP-ribo-
syl)ation reactions in the regulation of nuclear functions.  Bio-
chem J 1999, 342(Pt 2):249-268.
62. Hassa PO, Haenni SS, Elser M, Hottiger MO: Nuclear ADP-ribo-
sylation reactions in mammalian cells: where are we today
and where are we going?  Microbiol Mol Biol Rev 2006,
70(3):789-829.
63. Langelier MF, Servent KM, Rogers EE, Pascal JM: A third zinc-bind-
ing domain of human poly(ADP-ribose) polymerase-1 coor-
dinates DNA-dependent enzyme activation.  The Journal of
biological chemistry 2008, 283(7):4105-4114.
64. Tao Z, Gao P, Hoffman DW, Liu HW: Domain C of human
poly(ADP-ribose) polymerase-1 is important for enzyme
activity and contains a novel zinc-ribbon motif.  Biochemistry
2008, 47(21):5804-5813.
65. Schreiber V, Molinete M, Boeuf H, de Murcia G, Menissier-de Murcia
J: The human poly(ADP-ribose) polymerase nuclear localiza-
tion signal is a bipartite element functionally separate from
DNA binding and catalytic activity.  EMBO J 1992,
11(9):3263-3269.
66. Pion E, Ullmann GM, Ame JC, Gerard D, de Murcia G, Bombarda E:
DNA-induced dimerization of poly(ADP-ribose) polymer-
ase-1 triggers its activation.  Biochemistry 2005,
44(44):14670-14681.
67. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO: Molecular
mechanism of poly(ADP-ribosyl)ation by PARP1 and identi-
fication of lysine residues as ADP-ribose acceptor sites.
Nucleic acids research 2009, 37(11):3723-3738.
68. Zaremba T, Ketzer P, Cole M, Coulthard S, Plummer ER, Curtin NJ:
Poly(ADP-ribose) polymerase-1 polymorphisms, expression
and activity in selected human tumour cell lines.  Br J Cancer
2009, 101(2):256-262.
69. Ogata N, Ueda K, Kagamiyama H, Hayaishi O: ADP-ribosylation of
histone H1. Identification of glutamic acid residues 2, 14, and
the COOH-terminal lysine residue as modification sites.  The
Journal of biological chemistry 1980, 255(16):7616-7620.
70. Diefenbach J, Burkle A: Introduction to poly(ADP-ribose)
metabolism.  Cell Mol Life Sci 2005, 62(7-8):721-730.
71. Mendoza-Alvarez H, Alvarez-Gonzalez R: Poly(ADP-ribose)
polymerase is a catalytic dimer and the automodification
reaction is intermolecular.  J Biol Chem 1993,
268(30):22575-22580.
72. Adamietz P, Rudolph A: ADP-ribosylation of nuclear proteins in
vivo. Identification of histone H2B as a major acceptor for
mono- and poly(ADP-ribose) in dimethyl sulfate-treated
hepatoma AH 7974 cells.  J Biol Chem 1984, 259(11):6841-6846.
73. Poirier GG, de Murcia G, Jongstra-Bilen J, Niedergang C, Mandel P:
Poly(ADP-ribosyl)ation of polynucleosomes causes relaxa-
tion of chromatin structure.  Proc Natl Acad Sci USA 1982,
79(11):3423-3427.
74. Atorino L, Alvarez-Gonzalez R, Cardone A, Lepore I, Farina B, Que-
sada P: Metabolic changes in the poly(ADP-ribosyl)ation path-
way of differentiating rat germinal cells.  Arch Biochem Biophys
2000, 381(1):111-118.
75. Mendoza-Alvarez H, Alvarez-Gonzalez R: Regulation of p53
sequence-specific DNA-binding by covalent poly(ADP-ribo-
syl)ation.  J Biol Chem 2001, 276(39):36425-36430.
76. Yoshihara K, Itaya A, Tanaka Y, Ohashi Y, Ito K, Teraoka H, Tsukada
K, Matsukage A, Kamiya T: Inhibition of DNA polymerase alpha,
DNA polymerase beta, terminal deoxynucleotidyl trans-
ferase, and DNA ligase II by poly(ADP-ribosyl)ation reaction
in vitro.  Biochem Biophys Res Commun 1985, 128(1):61-67.
77. Scovassi AI, Mariani C, Negroni M, Negri C, Bertazzoni U: ADP-
ribosylation of nonhistone proteins in HeLa cells: modifica-
tion of DNA topoisomerase II.  Exp Cell Res 1993,
206(1):177-181.
78. Kameoka M, Ota K, Tetsuka T, Tanaka Y, Itaya A, Okamoto T, Yoshi-
hara K: Evidence for regulation of NF-kappaB by poly(ADP-
ribose) polymerase.  Biochem J 2000, 346(Pt 3):641-649.
79. Huang K, Tidyman WE, Le KU, Kirsten E, Kun E, Ordahl CP: Analy-
sis of nucleotide sequence-dependent DNA binding of
poly(ADP-ribose) polymerase in a purified system.  Biochemis-
try 2004, 43(1):217-223.
80. Bauer PI, Kenesi E, Mendeleyev J, Kun E: The influence of ATP on
poly(ADP-ribose) metabolism.  Int J Mol Med 2005,
16(2):321-324.
81. Kolthur-Seetharam U, Dantzer F, McBurney MW, de Murcia G, Sas-
sone-Corsi P: Control of AIF-mediated cell death by the func-
tional interplay of SIRT1 and PARP-1 in response to DNA
damage.  Cell Cycle 2006, 5(8):873-877.
82. Ermak G, Davies KJ: Calcium and oxidative stress: from cell sig-
naling to cell death.  Mol Immunol 2002, 38(10):713-721.
83. Schwerdtle T, Hamann I, Jahnke G, Walter I, Richter C, Parsons JL,
Dianov GL, Hartwig A: Impact of copper on the induction and
repair of oxidative DNA damage, poly(ADP-ribosyl)ation
and PARP-1 activity.  Mol Nutr Food Res 2007, 51(2):201-210.
84. Midorikawa R, Takei Y, Hirokawa N: KIF4 motor regulates activ-
ity-dependent neuronal survival by suppressing PARP-1
enzymatic activity.  Cell 2006, 125(2):371-383.
85. Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N,
Franceschi C, Gaetti R, Cavalieri E, Suzuki H: Metallothioneins/
PARP-1/IL-6 interplay on natural killer cell activity in elderly:
parallelism with nonagenarians and old infected humans.
Effect of zinc supply.  Mech Ageing Dev 2003, 124(4):459-468.
86. Kun E, Kirsten E, Ordahl CP: Coenzymatic activity of randomly
broken or intact double-stranded DNAs in auto and histone
H1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-
ribose) polymerase (PARP I).  The Journal of biological chemistry
2002, 277(42):39066-39069.
87. Geraets L, Moonen HJ, Wouters EF, Bast A, Hageman GJ: Caffeine
metabolites are inhibitors of the nuclear enzyme poly(ADP-
ribose)polymerase-1 at physiological concentrations.  Bio-
chem Pharmacol 2006, 72(7):902-910.
88. Kauppinen TM, Chan WY, Suh SW, Wiggins AK, Huang EJ, Swanson
RA:  Direct phosphorylation and regulation of poly(ADP-
ribose) polymerase-1 by extracellular signal-regulated
kinases 1/2.  Proc Natl Acad Sci USA 2006, 103(18):7136-7141.
89. Ariumi Y, Masutani M, Copeland TD, Mimori T, Sugimura T, Shimo-
tohno K, Ueda K, Hatanaka M, Noda M: Suppression of the
poly(ADP-ribose) polymerase activity by DNA-dependent
protein kinase in vitro.  Oncogene 1999, 18(32):4616-4625.
90. Audebert M, Salles B, Calsou P: Effect of double-strand break
DNA sequence on the PARP-1 NHEJ pathway.  Biochem Biophys
Res Commun 2008, 369(3):982-988.
91. Chen J, Tomkinson AE, Ramos W, Mackey ZB, Danehower S, Walter
CA, Schultz RA, Besterman JM, Husain I: Mammalian DNA ligase
III: molecular cloning, chromosomal localization, and
expression in spermatocytes undergoing meiotic recombi-
nation.  Mol Cell Biol 1995, 15(10):5412-5422.Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 17 of 20
(page number not for citation purposes)
92. Kotoglou P, Kalaitzakis A, Vezyraki P, Tzavaras T, Michalis LK, Dan-
tzer F, Jung JU, Angelidis C: Hsp70 translocates to the nuclei and
nucleoli, binds to XRCC1 and PARP-1, and protects HeLa
cells from single-strand DNA breaks.  Cell Stress Chaperones
2009, 14(4):391-406.
93. Leppard JB, Dong Z, Mackey ZB, Tomkinson AE: Physical and func-
tional interaction between DNA ligase IIIalpha and
poly(ADP-Ribose) polymerase 1 in DNA single-strand break
repair.  Mol Cell Biol 2003, 23(16):5919-5927.
94. Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de
Murcia G, Schreiber V: Base excision repair is impaired in mam-
malian cells lacking Poly(ADP-ribose) polymerase-1.  Bio-
chemistry 2000, 39(25):7559-7569.
95. Parsons JL, Dianova II, Allinson SL, Dianov GL: Poly(ADP-ribose)
polymerase-1 protects excessive DNA strand breaks from
deterioration during repair in human cell extracts.  FEBS J
2005, 272(8):2012-2021.
96. Sagan D, Muller R, Kroger C, Hematulin A, Mortl S, Eckardt-Schupp
F: The DNA repair protein NBS1 influences the base excision
repair pathway.  Carcinogenesis 2009, 30(3):408-415.
97. Quenet D, El Ramy R, Schreiber V, Dantzer F: The role of
poly(ADP-ribosyl)ation in epigenetic events.  Int J Biochem Cell
Biol 2009, 41(1):60-65.
98. Mortusewicz O, Ame JC, Schreiber V, Leonhardt H: Feedback-reg-
ulated poly(ADP-ribosyl)ation by PARP-1 is required for
rapid response to DNA damage in living cells.  Nucleic Acids Res
2007, 35(22):7665-7675.
99. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ: Poly-
ADP ribose polymerase activates nuclear proteasome to
degrade oxidatively damaged histones.  Proc Natl Acad Sci USA
1999, 96(11):6223-6228.
100. Mathieu J, Flexor M, Lanotte M, Besancon F: A PARP-1/JNK1 cas-
cade participates in the synergistic apoptotic effect of
TNFalpha and all-trans retinoic acid in APL cells.  Oncogene
2008, 27(24):3361-3370.
101. Heeres JT, Hergenrother PJ: Poly(ADP-ribose) makes a date
with death.  Curr Opin Chem Biol 2007, 11(6):644-653.
102. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina
R, Muller S, de la Rubia G, Stoclet JC, de Murcia G: Resistance to
endotoxic shock as a consequence of defective NF-kappaB
activation in poly (ADP-ribose) polymerase-1 deficient mice.
EMBO J 1999, 18(16):4446-4454.
103. Zerfaoui M, Suzuki Y, Naura AS, Hans CP, Nichols C, Boulares AH:
Nuclear translocation of p65 NF-kappaB is sufficient for
VCAM-1, but not ICAM-1, expression in TNF-stimulated
smooth muscle cells: Differential requirement for PARP-1
expression and interaction.  Cell Signal 2008, 20(1):186-194.
104. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG:
Specific proteolytic cleavage of poly(ADP-ribose) polymer-
ase: an early marker of chemotherapy-induced apoptosis.
Cancer Res 1993, 53(17):3976-3985.
105. D'Amours D, Sallmann FR, Dixit VM, Poirier GG: Gain-of-function
of poly(ADP-ribose) polymerase-1 upon cleavage by apop-
totic proteases: implications for apoptosis.  J Cell Sci 2001,
114(Pt 20):3771-3778.
106. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ,
Poirier GG, Dawson TM, Dawson VL: Mediation of poly(ADP-
ribose) polymerase-1-dependent cell death by apoptosis-
inducing factor.  Science 2002, 297(5579):259-263.
107. Tramontano F, Malanga M, Quesada P: Differential contribution
of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to
the poly(ADP-ribosyl)ation reaction in rat primary sperma-
tocytes.  Mol Hum Reprod 2007, 13(11):821-828.
108. Tulin A, Chinenov Y, Spradling A: Regulation of chromatin struc-
ture and gene activity by poly(ADP-ribose) polymerases.
Curr Top Dev Biol 2003, 56:55-83.
109. Berger NA, Sims JL, Catino DM, Berger SJ: Poly(ADP-ribose)
polymerase mediates the suicide response to massive DNA
damage: studies in normal and DNA-repair defective cells.
Princess Takamatsu Symp 1983, 13:219-226.
110. Andrabi SA, Dawson TM, Dawson VL: Mitochondrial and Nuclear
Cross Talk in Cell Death Parthanatos.  Annals of the New York
Academy of Sciences 2008, 1147:233-241.
1 1 1 . K a n a i  M ,  U c h i d a  M ,  H a n a i  S ,  U e m a t s u  N ,  U c h i d a  K ,  M i w a  M :
Poly(ADP-ribose) polymerase localizes to the centrosomes
and chromosomes.  Biochem Biophys Res Commun 2000,
278(2):385-389.
112. Chang P, Jacobson MK, Mitchison TJ: Poly(ADP-ribose) is
required for spindle assembly and structure.  Nature 2004,
432(7017):645-649.
113. Kanai M, Tong WM, Sugihara E, Wang ZQ, Fukasawa K, Miwa M:
Involvement of poly(ADP-Ribose) polymerase 1 and
poly(ADP-Ribosyl)ation in regulation of centrosome func-
tion.  Mol Cell Biol 2003, 23(7):2451-2462.
114. Earle E, Saxena A, MacDonald A, Hudson DF, Shaffer LG, Saffery R,
Cancilla MR, Cutts SM, Howman E, Choo KH: Poly(ADP-ribose)
polymerase at active centromeres and neocentromeres at
metaphase.  Hum Mol Genet 2000, 9(2):187-194.
115. Saxena A, Wong LH, Kalitsis P, Earle E, Shaffer LG, Choo KH:
Poly(ADP-ribose) polymerase 2 localizes to mammalian
active centromeres and interacts with PARP-1, Cenpa,
Cenpb and Bub3, but not Cenpc.  Hum Mol Genet 2002,
11(19):2319-2329.
116. Faraone-Mennella MR: Chromatin architecture and functions:
the role(s) of poly(ADP-RIBOSE) polymerase and
poly(ADPribosyl)ation of nuclear proteins.  Biochem Cell Biol
2005, 83(3):396-404.
117. Kraus WL, Lis JT: PARP goes transcription.  Cell 2003,
113(6):677-683.
118. Kraus WL: Transcriptional control by PARP-1: chromatin
modulation, enhancer-binding, coregulation, and insulation.
Curr Opin Cell Biol 2008, 20(3):294-302.
119. Quenet D, Gasser V, Fouillen L, Cammas F, Sanglier-Cianferani S, Los-
son R, Dantzer F: The histone subcode: poly(ADP-ribose)
polymerase-1 (Parp-1) and Parp-2 control cell differentiation
by regulating the transcriptional intermediary factor
TIF1beta and the heterochromatin protein HP1alpha.  FASEB
J 2008, 22(11):3853-3865.
120. Huang JY, Chen WH, Chang YL, Wang HT, Chuang WT, Lee SC:
Modulation of nucleosome-binding activity of FACT by
poly(ADP-ribosyl)ation.  Nucleic Acids Res 2006, 34(8):2398-2407.
121. Poirier GG, de Murcia G, Jongstra-Bilen J, Niedergang C, Mandel P:
Poly(ADP-ribosyl)ation of polynucleosomes causes relaxa-
tion of chromatin structure.  Proc Natl Acad Sci USA 1982,
79(11):3423-3427.
122. Rouleau M, Aubin RA, Poirier GG: Poly(ADP-ribosyl)ated chro-
matin domains: access granted.  J Cell Sci 2004, 117(Pt
6):815-825.
123. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M,
Kraus WL: Reciprocal binding of PARP-1 and histone H1 at
promoters specifies transcriptional outcomes.  Science 2008,
319(5864):819-821.
124. Oei SL, Griesenbeck J, Schweiger M, Ziegler M: Regulation of RNA
polymerase II-dependent transcription by poly(ADP-ribo-
syl)ation of transcription factors.  The Journal of biological chemis-
try 1998, 273(48):31644-31647.
125. Yazawa T, Fujimoto K, Yamamoto T, Abe SI: Caspase activity in
newt spermatogonial apoptosis induced by prolactin and
cycloheximide.  Mol Reprod Dev 2001, 59(2):209-214.
126. Ye K: PARP inhibitor tilts cell death from necrosis to apopto-
sis in cancer cells.  Cancer Biol Ther 2008, 7(6):942-944.
127. Mizuno K, Hayashi Y, Kojima Y, Nakane A, Tozawa K, Kohri K: Acti-
vation of NF-kappaB associated with germ cell apoptosis in
testes of experimentally induced cryptorchid rat model.
Urology 2009, 73(2):389-393.
128. Varisli O, Uguz C, Agca C, Agca Y: Various physical stress factors
on rat sperm motility, integrity of acrosome, and plasma
membrane.  J Androl 2009, 30(1):75-86.
129. Tanori M, Mancuso M, Pasquali E, Leonardi S, Rebessi S, Di Majo V,
Guilly MN, Giangaspero F, Covelli V, Pazzaglia S, Saran A: PARP-1
cooperates with Ptc1 to suppress medulloblastoma and
basal cell carcinoma.  Carcinogenesis 2008, 29(10):1911-1919.
130. Spina-Purrello V, Patti D, Giuffrida-Stella AM, Nicoletti VG: Parp and
cell death or protection in rat primary astroglial cell cultures
under LPS/IFNgamma induced proinflammatory conditions.
Neurochem Res 2008, 33(12):2583-2592.
131. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Far-
rar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, Oshimura M,
Feinberg AP, Lobanenkov V, Klenova E, Ohlsson R: Poly(ADP-ribo-
syl)ation regulates CTCF-dependent chromatin insulation.
Nat Genet 2004, 36(10):1105-1110.Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 18 of 20
(page number not for citation purposes)
132. Thornberry NA, Lazebnik Y: Caspases: enemies within.  Science
1998, 281(5381):1312-1316.
133. Ullrich O, Reinheckel T, Sitte N, Hass R, Grune T, Davies KJ: Poly-
ADP ribose polymerase activates nuclear proteasome to
degrade oxidatively damaged histones.  Proc Natl Acad Sci USA
1999, 96(11):6223-6228.
134. Klenova E, Ohlsson R: Poly(ADP-ribosyl)ation and epigenetics.
Is CTCF PARt of the plot?  Cell Cycle 2005, 4(1):96-101.
135. Guastafierro T, Cecchinelli B, Zampieri M, Reale A, Riggio G, Sthand-
ier O, Zupi G, Calabrese L, Caiafa P: CCCTC-binding factor acti-
vates PARP-1 affecting DNA methylation machinery.  The
Journal of biological chemistry 2008, 283(32):21873-21880.
136. Winstall E, Affar EB, Shah R, Bourassa S, Scovassi IA, Poirier GG:
Preferential perinuclear localization of poly(ADP-ribose)
glycohydrolase.  Exp Cell Res 1999, 251(2):372-378.
137. Davidovic L, Vodenicharov M, Affar EB, Poirier GG: Importance of
poly(ADP-ribose) glycohydrolase in the control of
poly(ADP-ribose) metabolism.  Exp Cell Res 2001, 268(1):7-13.
138. Koh DW, Lawler AM, Poitras MF, Sasaki M, Wattler S, Nehls MC,
Stoger T, Poirier GG, Dawson VL, Dawson TM: Failure to degrade
poly(ADP-ribose) causes increased sensitivity to cytotoxicity
and early embryonic lethality.  Proc Natl Acad Sci USA 2004,
101(51):17699-17704.
139. Blenn C, Althaus FR, Malanga M: Poly(ADP-ribose) glycohydro-
lase silencing protects against H2O2-induced cell death.  Bio-
chem J 2006, 396(3):419-429.
140. Fisher AE, Hochegger H, Takeda S, Caldecott KW: Poly(ADP-
ribose) polymerase 1 accelerates single-strand break repair
in concert with poly(ADP-ribose) glycohydrolase.  Mol Cell Biol
2007, 27(15):5597-5605.
141. Baum JS, St George JP, McCall K: Programmed cell death in the
germline.  Semin Cell Dev Biol 2005, 16(2):245-259.
142. Print CG, Loveland KL: Germ cell suicide: new insights into
apoptosis during spermatogenesis.  Bioessays 2000,
22(5):423-430.
143. Codelia VA, Cisternas P, Moreno RD: Relevance of caspase activ-
ity during apoptosis in pubertal rat spermatogenesis.  Mol
Reprod Dev 2008, 75(5):881-889.
144. Ohashi Y, Ueda K, Kawaichi M, Hayaishi O: Activation of DNA
ligase by poly(ADP-ribose) in chromatin.  Proc Natl Acad Sci USA
1983, 80(12):3604-3607.
145. Spina-Purrello V, Patti D, Giuffrida-Stella AM, Nicoletti VG: Parp and
Cell Death or Protection in Rat Primary Astroglial Cell Cul-
tures Under LPS/IFNgamma Induced Proinflammatory
Conditions.  Neurochem Res 2008.
146. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR,
Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32 beta, a mam-
malian homolog of CED-3, is a CrmA-inhibitable protease
that cleaves the death substrate poly(ADP-ribose) polymer-
ase.  Cell 1995, 81(5):801-809.
147. Pacher P, Szabo C: Role of the peroxynitrite-poly(ADP-ribose)
polymerase pathway in human disease.  Am J Pathol 2008,
173(1):2-13.
148. Duriez PJ, Shah GM: Cleavage of poly(ADP-ribose) polymerase:
a sensitive parameter to study cell death.  Biochem Cell Biol
1997, 75(4):337-349.
149. Hadziselimovic F, Geneto R, Emmons LR: Increased apoptosis in
the contralateral testes of patients with testicular torsion as
a factor for infertility.  J Urol 1998, 160(3 Pt 2):1158-1160.
150. Lin WW, Lamb DJ, Wheeler TM, Lipshultz LI, Kim ED: In situ end-
labeling of human testicular tissue demonstrates increased
apoptosis in conditions of abnormal spermatogenesis.  Fertil
Steril 1997, 68(6):1065-1069.
151. Kim SK, Yoon YD, Park YS, Seo JT, Kim JH: Involvement of the
Fas-Fas ligand system and active caspase-3 in abnormal
apoptosis in human testes with maturation arrest and Ser-
toli cell-only syndrome.  Fertility and sterility 2007, 87(3):547-553.
152. Tesarik J, Greco E, Cohen-Bacrie P, Mendoza C: Germ cell apop-
tosis in men with complete and incomplete spermiogenesis
failure.  Mol Hum Reprod 1998, 4(8):757-762.
153. Maymon BB, Cohen-Armon M, Yavetz H, Yogev L, Lifschitz-Mercer
B, Kleiman SE, Botchan A, Hauser R, Paz G: Role of poly(ADP-
ribosyl)ation during human spermatogenesis.  Fertil Steril 2006,
86(5):1402-1407.
154. Dantzer F, Ame JC, Schreiber V, Nakamura J, Menissier-de Murcia J,
de Murcia G: Poly(ADP-ribose) polymerase-1 activation dur-
ing DNA damage and repair.  Methods Enzymol 2006,
409:493-510.
155. Hikim AP, Vera Y, Vernet D, Castanares M, Diaz-Romero M, Ferrini
M, Swerdloff RS, Gonzalez-Cadavid NF, Wang C: Involvement of
nitric oxide-mediated intrinsic pathway signaling in age-
related increase in germ cell apoptosis in male Brown-Nor-
way rats.  J Gerontol A Biol Sci Med Sci 2005, 60(6):702-708.
156. Miura M, Sasagawa I, Suzuki Y, Nakada T, Fujii J: Apoptosis and
expression of apoptosis-related genes in the mouse testis fol-
lowing heat exposure.  Fertil Steril 2002, 77(4):787-793.
157. Aguilar-Quesada R, Munoz-Gamez JA, Martin-Oliva D, Peralta-Leal A,
Quiles-Perez R, Rodriguez-Vargas JM, de Almodovar MR, Conde C,
Ruiz-Extremera A, Oliver FJ: Modulation of transcription by
PARP-1: consequences in carcinogenesis and inflammation.
Curr Med Chem 2007, 14(11):1179-1187.
158. Pentikainen V, Suomalainen L, Erkkila K, Martelin E, Parvinen M, Pen-
tikainen MO, Dunkel L: Nuclear factor-kappa B activation in
human testicular apoptosis.  Am J Pathol 2002, 160(1):205-218.
159. Chiarugi A: Poly(ADP-ribosyl)ation and stroke.  Pharmacol Res
2005, 52(1):15-24.
160. Di Meglio S, Denegri M, Vallefuoco S, Tramontano F, Scovassi AI,
Quesada P: Poly(ADPR) polymerase-1 and poly(ADPR) glyco-
hydrolase level and distribution in differentiating rat germi-
nal cells.  Mol Cell Biochem 2003, 248(1-2):85-91.
161. Quesada P, Atorino L, Cardone A, Ciarcia G, Farina B: Poly(ADPri-
bosyl)ation system in rat germinal cells at different stages of
differentiation.  Exp Cell Res 1996, 226(1):183-190.
162. Wouters-Tyrou D, Martinage A, Chevaillier P, Sautiere P: Nuclear
basic proteins in spermiogenesis.  Biochimie 1998,
80(2):117-128.
163. Ward WS, Coffey DS: DNA packaging and organization in
mammalian spermatozoa: comparison with somatic cells.
Biol Reprod 1991, 44(4):569-574.
164. Marcon L, Boissonneault G: Transient DNA strand breaks dur-
ing mouse and human spermiogenesis new insights in stage
specificity and link to chromatin remodeling.  Biol Reprod 2004,
70(4):910-918.
165. Meyer-Ficca ML, Lonchar J, Credidio C, Ihara M, Li Y, Wang ZQ,
Meyer RG: Disruption of poly(ADP-ribose) homeostasis
affects spermiogenesis and sperm chromatin integrity in
mice.  Biology of reproduction 2009, 81(1):46-55.
166. Kaipia A, Toppari J, Mali P, Kangasniemi M, Alcivar AA, Hecht NB,
Parvinen M: Stage- and cell-specific expression of the ornithine
decarboxylase gene during rat and mouse spermatogenesis.
Molecular and cellular endocrinology 1990, 73(1):45-52.
167. Taylor SL, Weng SL, Fox P, Duran EH, Morshedi MS, Oehninger S,
Beebe SJ: Somatic cell apoptosis markers and pathways in
human ejaculated sperm: potential utility as indicators of
sperm quality.  Molecular human reproduction 2004,
10(11):825-834.
168. Jha R, Agarwal A, Mahfouz R, Paasch U, Grunewald S, Sabanegh E,
Yadav SP, Sharma R: Determination of Poly (ADP-ribose)
polymerase (PARP) homologues in human ejaculated sperm
and its correlation with sperm maturation.  Fertility and sterility
2009, 91(3):782-790.
169. Benchaib M, Lornage J, Mazoyer C, Lejeune H, Salle B, Francois
Guerin J: Sperm deoxyribonucleic acid fragmentation as a
prognostic indicator of assisted reproductive technology
outcome.  Fertil Steril 2007, 87(1):93-100.
170. Kopeika J, Kopeika E, Zhang T, Rawson DM, Holt WV: Effect of
DNA repair inhibitor (3-aminobenzamide) on genetic stabil-
ity of loach (Misgurnus fossilis) embryos derived from cryop-
reserved sperm.  Theriogenology 2004, 61(9):1661-1673.
171. Meseguer M, Santiso R, Garrido N, Fernandez JL: The effect of can-
cer on sperm DNA fragmentation as measured by the sperm
chromatin dispersion test.  Fertil Steril 2008, 90(1):225-227.
172. O'Flaherty C, Vaisheva F, Hales BF, Chan P, Robaire B: Characteri-
zation of sperm chromatin quality in testicular cancer and
Hodgkin's lymphoma patients prior to chemotherapy.  Hum
Reprod 2008, 23(5):1044-1052.
173. Edelstein A, Yavetz H, Kleiman SE, Botchan A, Hauser R, Paz G, Yogev
L: Deoxyribonucleic acid-damaged sperm in cryopreserved-
thawed specimens from cancer patients and healthy men.
Fertil Steril 2008, 90(1):205-208.
174. Spermon JR, Ramos L, Wetzels AM, Sweep CG, Braat DD, Kiemeney
LA, Witjes JA: Sperm integrity pre- and post-chemotherapy inReproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 19 of 20
(page number not for citation purposes)
men with testicular germ cell cancer.  Hum Reprod 2006,
21(7):1781-1786.
175. Mitchell RT, Saunders PT, Sharpe RM, Kelnar CJ, Wallace WH: Male
fertility and strategies for fertility preservation following
childhood cancer treatment.  Endocr Dev 2009, 15:101-134.
176. Wang T, Simbulan-Rosenthal CM, Smulson ME, Chock PB, Yang DC:
Polyubiquitylation of PARP-1 through ubiquitin K48 is mod-
ulated by activated DNA, NAD+, and dipeptides.  J Cell Bio-
chem 2008, 104(1):318-328.
177. Wang Y, Virji AS, Howard P, Sayani Y, Zhang J, Achu P, McArthur C:
Detection of cleaved alpha-fodrin autoantigen in Sjogren's
syndrome: apoptosis and co-localisation of cleaved alpha-
fodrin with activated caspase-3 and cleaved poly(ADP-
ribose) polymerase (PARP) in labial salivary glands.  Arch Oral
Biol 2006, 51(7):558-566.
178. Olsen GJ: The history of life.  Nat Genet 2001, 28(3):197-198.
179. Kovtun IV, McMurray CT: Trinucleotide expansion in haploid
germ cells by gap repair.  Nat Genet 2001, 27(4):407-411.
180. Kovtun IV, McMurray CT: Features of trinucleotide repeat
instability in vivo.  Cell research 2008, 18(1):198-213.
181. Kovtun IV, Welch G, Guthrie HD, Hafner KL, McMurray CT: CAG
repeat lengths in X- and Y-bearing sperm indicate that gen-
der bias during transmission of Huntington's disease gene is
determined in the embryo.  J Biol Chem 2004,
279(10):9389-9391.
182. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV,
Badger JD, Terzic A, Estevez A, Windebank AJ, Dyer RB, Yao J,
McMurray CT: Microtubule destabilization and nuclear entry
are sequential steps leading to toxicity in Huntington's dis-
ease.  Proc Natl Acad Sci USA 2003, 100(21):12171-12176.
183. Rybaczek D, Bodys A, Maszewski J: H2AX foci in late S/G2- and
M-phase cells after hydroxyurea- and aphidicolin-induced
DNA replication stress in Vicia.  Histochemistry and cell biology
2007, 128(3):227-241.
184. Leduc F, Maquennehan V, Nkoma GB, Boissonneault G: DNA dam-
age response during chromatin remodeling in elongating
spermatids of mice.  Biol Reprod 2008, 78(2):324-332.
185. Quesada P, Tramontano F, Faraone-Mennella MR, Farina B: The
analysis of the poly(ADPR) polymerase mode of action in rat
testis nuclear fractions defines a specific poly(ADP-ribo-
syl)ation system associated with the nuclear matrix.  Mol Cell
Biochem 2000, 205(1-2):91-99.
186. Tramontano F, Malanga M, Farina B, Jones R, Quesada P: Heat stress
reduces poly(ADPR)polymerase expression in rat testis.  Mol
Hum Reprod 2000, 6(7):575-581.
187. Jaroudi S, SenGupta S: DNA repair in mammalian embryos.
Mutat Res 2007, 635(1):53-77.
188. Marchetti C, Gallego MA, Defossez A, Formstecher P, Marchetti P:
Staining of human sperm with fluorochrome-labeled inhibi-
tor of caspases to detect activated caspases: correlation with
apoptosis and sperm parameters.  Hum Reprod 2004,
19(5):1127-1134.
189. Paasch U, Grunewald S, Agarwal A, Glandera HJ: Activation pat-
tern of caspases in human spermatozoa.  Fertility and sterility
2004, 81(Suppl 1):802-809.
190. Grunewald S, Sharma R, Paasch U, Glander HJ, Agarwal A: Impact
of caspase activation in human spermatozoa.  Microsc Res Tech
2009 in press.
191. Almeida C, Cardoso MF, Sousa M, Viana P, Goncalves A, Silva J, Bar-
ros A: Quantitative study of caspase-3 activity in semen and
after swim-up preparation in relation to sperm quality.  Hum
Reprod 2005, 20(5):1307-1313.
192. Weng SL, Taylor SL, Morshedi M, Schuffner A, Duran EH, Beebe S,
Oehninger S: Caspase activity and apoptotic markers in ejacu-
lated human sperm.  Molecular human reproduction 2002,
8(11):984-991.
193. Paasch U, Grunewald S, Fitzl G, Glander HJ: Deterioration of
plasma membrane is associated with activated caspases in
human spermatozoa.  J Androl 2003, 24(2):246-252.
194. Faleiro L, Lazebnik Y: Caspases disrupt the nuclear-cytoplasmic
barrier.  J Cell Biol 2000, 151(5):951-959.
195. Buelow B, Song Y, Scharenberg AM: The Poly(ADP-ribose)
Polymerase PARP-1 Is Required for Oxidative Stress-
induced TRPM2 Activation in Lymphocytes.  J Biol Chem 2008,
283(36):24571-24583.
196. Xu B, Chiu J, Feng B, Chen S, Chakrabarti S: PARP activation and
the alteration of vasoactive factors and extracellular matrix
protein in retina and kidney in diabetes.  Diabetes Metab Res Rev
2008, 24(5):404-412.
197. Blanc-Layrac G, Bringuier AF, Guillot R, Feldmann G: Morphological
and biochemical analysis of cell death in human ejaculated
spermatozoa.  Cell Mol Biol (Noisy-le-grand) 2000, 46(1):187-197.
198. El-Domyati MM, Al-Din AB, Barakat MT, El-Fakahany HM, Xu J, Sak-
kas D: Deoxyribonucleic acid repair and apoptosis in testicu-
lar germ cells of aging fertile men: the role of the
poly(adenosine diphosphate-ribosyl)ation pathway.  Fertility
and sterility 2009, 91(5 Suppl):2221-2229.
199. Mahfouz RZ, Sharma RK, Poenicke K, Jha R, Paasch U, Grunewald S,
Agarwal A: Evaluation of poly(ADP-ribose) polymerase cleav-
age (cPARP) in ejaculated human sperm fractions after
induction of apoptosis.  Fertility and sterility 2009, 91(5
Suppl):2210-2220.
200. Kefer JC, Agarwal A, Sabanegh E: Role of antioxidants in the
treatment of male infertility.  Int J Urol 2009, 16(5):449-457.
201. Makker K, Agarwal A, Sharma R: Oxidative stress & male infer-
tility.  Indian J Med Res 2009, 129(4):357-367.
202. Reddy M, Mahipal S, Subhashini J, Reddy M, Roy K, Reddy G, Reddy P,
Reddanna P: Bacterial lipopolysaccharide-induced oxidative
stress in the impairment of steroidogenesis and sperma-
togenesis in rats.  Reprod Toxicol 2006, 22:493-500.
203. Mahfouz R, Sharma R, Sharma D, Sabanegh E, Agarwal A: Diagnostic
value of the total antioxidant capacity (TAC) in human sem-
inal plasma.  Fertility and sterility 2009, 91(3):805-811.
204. Vaithinathan S, Saradha B, Mathur PP: Transient inhibitory effect
of methoxychlor on testicular steroidogenesis in rat: an in
vivo study.  Arch Toxicol 2008, 82(11):833-839.
205. Sarkar O, Mathur PP: Adjudin-mediated germ cell depletion
alters the anti-oxidant status of adult rat testis.  Mol Reprod
Dev 2009, 76(1):31-37.
206. Saradha B, Vaithinathan S, Mathur PP: Lindane induces testicular
apoptosis in adult Wistar rats through the involvement of
Fas-FasL and mitochondria-dependent pathways.  Toxicology
2009, 255(3):131-139.
207. Sarkar O, Mathur P, Cheng C, Mruk D: Interleukin 1 alpha (IL1A)
is a novel regulator of the blood-testis barrier in the rat.  Biol
Reprod 2008, 78:445-454.
208. Erdelyi K, Bakondi E, Gergely P, Szabo C, Virag L: Pathophysiologic
role of oxidative stress-induced poly(ADP-ribose) polymer-
ase-1 activation: focus on cell death and transcriptional reg-
ulation.  Cell Mol Life Sci 2005, 62(7-8):751-759.
209. Chen H, Jia W, Xu X, Fan Y, Zhu D, Wu H, Xie Z, Zheng Z: Upreg-
ulation of PEDF expression by PARP inhibition contributes
to the decrease in hyperglycemia-induced apoptosis in
HUVECs.  Biochem Biophys Res Commun 2008, 369(2):718-724.
210. Chandak PG, Gaikwad AB, Tikoo K: Gallotannin ameliorates the
development of streptozotocin-induced diabetic nephropa-
thy by preventing the activation of PARP.  Phytother Res 2009,
23(1):72-77.
211. El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW: A require-
ment for PARP-1 for the assembly or stability of XRCC1
nuclear foci at sites of oxidative DNA damage.  Nucleic Acids
Res 2003, 31(19):5526-5533.
212. Liang Y, Lin SY, Brunicardi FC, Goss J, Li K: DNA damage response
pathways in tumor suppression and cancer treatment.  World
J Surg 2009, 33(4):661-666.
213. Ljungman M, Hanawalt PC: Efficient protection against oxidative
DNA damage in chromatin.  Mol Carcinog 1992, 5(4):264-269.
214. Huang SH, Xiong M, Chen XP, Xiao ZY, Zhao YF, Huang ZY: PJ34,
an inhibitor of PARP-1, suppresses cell growth and enhances
the suppressive effects of cisplatin in liver cancer cells.  Oncol
Rep 2008, 20(3):567-572.
215. Lin P, Lin C, Huang C, Fang J, Chuang M: 2,3,7,8-Tetrachlorod-
ibenzo-p-dioxin modulates the induction of DNA strand
breaks and poly(ADP-ribose) polymerase-1 activation by
17beta-estradiol in human breast carcinoma cells through
alteration of CYP1A1 and CYP1B1 expression.  Chem Res Tox-
icol 2008, 21(7):1337-1347.
216. Ma Q, Baldwin K, Renzelli A, McDaniel A, Dong L: TCDD-inducible
poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-
tetrachlorodibenzo-p-dioxin.  Biochem Biophys Res Commun 2001,
289(2):499-506.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Reproductive Biology and Endocrinology 2009, 7:143 http://www.rbej.com/content/7/1/143
Page 20 of 20
(page number not for citation purposes)
217. Beneke S, Burkle A: Poly(ADP-ribosyl)ation in mammalian
ageing.  Nucleic Acids Res 2007, 35(22):7456-7465.
218. Cohausz O, Althaus FR: Role of PARP-1 and PARP-2 in the
expression of apoptosis-regulating genes in HeLa cells.  Cell
Biol Toxicol 2009, 25(4):379-391.
219. Chiu HJ, Fischman DA, Hammerling U: Vitamin A depletion
causes oxidative stress, mitochondrial dysfunction, and
PARP-1-dependent energy deprivation.  FASEB J 2008,
22(11):3878-3887.
220. Dantzer F, Giraud-Panis MJ, Jaco I, Ame JC, Schultz I, Blasco M, Koer-
ing CE, Gilson E, Menissier-de Murcia J, de Murcia G, Schreiber V:
Functional interaction between poly(ADP-Ribose) polymer-
ase 2 (PARP-2) and TRF2: PARP activity negatively regu-
lates TRF2.  Mol Cell Biol 2004, 24(4):1595-1607.
221. Gomez M, Wu J, Schreiber V, Dunlap J, Dantzer F, Wang Y, Liu Y:
PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase
and protects eroded telomeres.  Mol Biol Cell 2006,
17(4):1686-1696.
222. Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP-
ribose) polymerase at human telomeres.  Science 1998,
282(5393):1484-1487.
223. Simbulan-Rosenthal CM, Haddad BR, Rosenthal DS, Weaver Z, Cole-
man A, Luo R, Young HM, Wang ZQ, Ried T, Smulson ME: Chromo-
somal aberrations in PARP(-/-) mice: genome stabilization in
immortalized cells by reintroduction of poly(ADP-ribose)
polymerase cDNA.  Proc Natl Acad Sci USA 1999,
96(23):13191-13196.
224. d'Adda di Fagagna F, Hande MP, Tong WM, Lansdorp PM, Wang ZQ,
Jackson SP: Functions of poly(ADP-ribose) polymerase in con-
trolling telomere length and chromosomal stability.  Nat
Genet 1999, 23(1):76-80.
225. Aitken RJ, Gordon E, Harkiss D, Twigg JP, Milne P, Jennings Z, Irvine
DS:  Relative impact of oxidative stress on the functional
competence and genomic integrity of human spermatozoa.
Biol Reprod 1998, 59(5):1037-1046.
226. Aitken RJ, Krausz C: Oxidative stress, DNA damage and the Y
chromosome.  Reproduction 2001, 122(4):497-506.
227. Mahfouz RZ, Said TM, Mangrola D, Agarwal A: Potential roles of
poly (ADP-ribose) polymerase in male reproduction.  Archives
of Medical Science 2009, 5(1A):S92-S98.
228. Adhikari S, Choudhury S, Mitra PS, Dubash JJ, Sajankila SP, Roy R:
Targeting base excision repair for chemosensitization.  Anti-
cancer Agents Med Chem 2008, 8(4):351-357.
229. de la Lastra CA, Villegas I, Sanchez-Fidalgo S: Poly(ADP-ribose)
polymerase inhibitors: new pharmacological functions and
potential clinical implications.  Curr Pharm Des 2007,
13(9):933-962.
230. Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S: Oleanolic acid
induces apoptosis in human leukemia cells through caspase
activation and poly(ADP-ribose) polymerase cleavage.  Acta
Biochim Biophys Sin (Shanghai) 2007, 39(10):803-809.